Vitamin B12 Deficiency
Vitamin B12 deficiency is a condition resulting from inadequate intake, absorption, or utilization of cobalamin, leading to megaloblastic anemia and neurological dysfunction such as subacute combined degeneration of the spinal cord.
Vitamin B12 Deficiency
Vitamin B12 (cobalamin) deficiency is a state of inadequate body stores of vitamin B12, leading to impaired DNA synthesis (megaloblastic anaemia), demyelination of nervous tissue (neuropsychiatric disease), and epithelial cell dysfunction. The name "cobalamin" reflects its chemical structure — "cobalt" sits at the centre of a corrin ring, making it the only vitamin that contains a metal ion.
Clinically, B12 deficiency manifests as a spectrum: from subclinical biochemical derangement → haematological disease (megaloblastic anaemia with pancytopenia) → neurological disease (subacute combined degeneration of the spinal cord, peripheral neuropathy, neuropsychiatric symptoms). Crucially, neurological manifestations can occur in the absence of haematological changes, because neurons require a higher B12 level to function than the bone marrow does [1][2].
Key Conceptual Point
B12 deficiency is not just "a type of anaemia" — it is a systemic disease. The anaemia is reversible, but neurological damage may be permanent if treatment is delayed. Always think of B12 deficiency in any patient with unexplained neuropsychiatric symptoms, even if the blood count is normal.
| Factor | Details |
|---|---|
| Prevalence | ~6% of adults aged < 60 years in Western populations; rises to 10–20% in the elderly (> 60 years). In Hong Kong, prevalence is significant due to a high rate of H. pylori infection, widespread PPI use, and an ageing population on metformin for DM. |
| Age | More common with advancing age — achlorhydria and atrophic gastritis increase with age, impairing food-bound B12 liberation. |
| Sex | For pernicious anaemia specifically: F > M, with median age of onset ~60 years [2]. |
| Geography/Ethnicity | More prevalent in populations with high rates of vegetarianism (e.g., South Asians), pernicious anaemia (Northern Europeans), and H. pylori (East Asians including Hong Kong Chinese). |
| HK-specific | In Prof. Kwong's study on Hong Kong subjects, there were zero cases of folate deficiency anaemia — meaning in the Hong Kong exam context, megaloblastic anaemia is essentially B12 deficiency until proven otherwise [3]. |
High Yield — Hong Kong Context
In front of Kwong, never say folate deficiency as a cause of megaloblastic anaemia — since in his paper on HK subjects there were zero cases [3]. In Hong Kong exams, megaloblastic anaemia = B12 deficiency in practice.
Think of risk factors in terms of the B12 absorption pathway — anything that disrupts intake, gastric processing, intestinal absorption, or increases demand:
| Category | Risk Factor | Mechanism |
|---|---|---|
| Dietary | Strict vegetarian / vegan diet | B12 is found almost exclusively in animal products (meat, fish, eggs, dairy). Plants do not synthesize B12. |
| Alcoholism | Poor dietary intake + direct toxic effect on GI mucosa + hepatic injury | |
| Gastric | Pernicious anaemia | Autoimmune destruction of parietal cells → ↓IF |
| H. pylori infection | Molecular mimicry — antibodies cross-react with H⁺/K⁺-ATPase on parietal cells | |
| Post-gastrectomy / bariatric surgery | Loss of parietal cells → ↓IF; loss of acid/pepsin → impaired B12 release from food proteins | |
| Chronic atrophic gastritis | Parietal cell loss → ↓IF + achlorhydria | |
| Intestinal | Ileal resection / Crohn's disease affecting terminal ileum | B12-IF complex is specifically absorbed in the terminal ileum |
| Blind loop syndrome (bacterial overgrowth) | Bacteria compete for and consume luminal B12 | |
| Coeliac disease | Generalized malabsorption (though primarily proximal small bowel) | |
| Fish tapeworm (Diphyllobothrium latum) | Parasite competes for dietary B12 in the gut lumen | |
| Short gut syndrome | Loss of absorptive surface, especially if terminal ileum is resected [4] | |
| Drugs | Proton pump inhibitors (PPIs) / H2 receptor antagonists | ↓Gastric acid → impaired dissociation of B12 from food proteins |
| Metformin | Impairs Ca²⁺-dependent absorption of B12-IF complex in the terminal ileum | |
| Colchicine, cholestyramine, neomycin | Various mechanisms of malabsorption | |
| Increased demand | Pregnancy, lactation | ↑B12 utilization for fetal/neonatal growth |
| Haemolytic anaemia | ↑erythropoiesis → ↑B12 demand | |
| Autoimmune | Other autoimmune diseases | Pernicious anaemia clusters with autoimmune thyroid disease (Hashimoto's, Graves'), Addison's disease, vitiligo, hypoparathyroidism, T1DM — Polyglandular Autoimmune Syndrome Type 2 (PAS-2) [1][5] |
4. Anatomy and Physiology of Vitamin B12 Absorption
Understanding the clinical features and causes of B12 deficiency requires a solid grasp of the normal absorption pathway. Let's walk through it step-by-step:
- B12 is found in meat, fish, eggs, and dairy products — it is synthesised by microorganisms (bacteria, archaea), not by animals or plants. Animals accumulate it via their gut microbiota or by eating other animals. [1]
- Liver stores are sufficient for approximately 3 years of use + there is an active enterohepatic circulation (~5–10 μg/day is excreted in bile and reabsorbed in the terminal ileum). This is why it takes years for deficiency to manifest after the cause begins — unlike folate, which has stores lasting only ~3 months. [1]
- Daily requirement: ~2–5 μg/day; typical Western diet provides 5–30 μg/day.
Step-by-step explanation:
-
Mouth & Stomach: Food-bound B12 is released by gastric acid (HCl) and pepsin. This is why PPIs and H2-blockers can cause deficiency — they reduce gastric acid, so B12 remains trapped in food proteins. Free B12 first binds R-binder (haptocorrin) from saliva — this is a temporary protective carrier.
-
Duodenum: Pancreatic proteases (trypsin) digest the R-binder, releasing B12. Free B12 then binds intrinsic factor (IF), a glycoprotein secreted by gastric parietal cells. This is the critical step — without IF, absorption drops to < 1% (passive diffusion only) [2].
-
Terminal Ileum: The B12-IF complex binds to a specific receptor called cubilin on the brush border of ileal enterocytes. This binding is calcium-dependent — this is why metformin (which interferes with Ca²⁺-dependent membrane action) reduces B12 absorption [1].
-
Portal Blood: Inside the enterocyte, IF is degraded and B12 is transferred to the blood. In the blood, B12 circulates bound to two proteins:
- Transcobalamin II (TCII): Carries the active fraction of B12 (only 10–30% of total serum B12), also called holotranscobalamin (holoTC) — this is what we measure nowadays [3].
- Haptocorrin (TCI/TCIII): Carries the inactive fraction (70–90% of total serum B12) — this is the "storage" form and is NOT readily available to tissues.
Why Total Serum B12 Can Be Misleading
Total serum B12 measures both active (TCII-bound) and inactive (haptocorrin-bound) fractions. A patient can have a "normal" total B12 but still be functionally deficient if most of the B12 is bound to haptocorrin. Conversely, in CML/myeloproliferative neoplasms, haptocorrin is overproduced → total B12 is elevated but the patient may still be functionally deficient. In the old days, CML/MPN diagnosis was based on an increase in serum B12 → because these conditions caused an increase in haptocorrin/TCIII [3]. Modern practice measures holotranscobalamin (active B12) for a more accurate assessment.
4.3 Biochemical Roles of Vitamin B12
B12 serves as a cofactor for two critical enzymatic reactions. Understanding these two reactions explains ALL the clinical features:
Methyl-B12 (methylcobalamin) is a cofactor of methionine synthase: Homocysteine → Methionine [1]
Homocysteine + Methyl-THF --[Methionine Synthase + Methyl-B12]--> Methionine + THF- Why this matters for DNA synthesis: The methyl group is transferred from methyl-tetrahydrofolate (methyl-THF) to homocysteine, regenerating THF (tetrahydrofolate). THF is then converted to methylene-THF, which is essential for thymidylate synthesis (dTMP), the rate-limiting step in DNA synthesis.
- The "Folate Trap" hypothesis: Without B12, methyl-THF cannot donate its methyl group → folate is "trapped" in the methyl-THF form → functional folate deficiency → impaired DNA synthesis → megaloblastic anaemia. This is why B12 deficiency traps folate into cells [1].
- Homocysteine accumulates → elevated serum homocysteine (a useful diagnostic marker; also a cardiovascular risk factor).
- Methionine cannot be synthesised → ↓S-adenosylmethionine (SAM) → impaired methylation reactions throughout the body, including methylation of myelin basic protein → this is thought to contribute to the neurological damage in B12 deficiency.
Adenosyl-B12 (adenosylcobalamin) converts methylmalonyl-CoA (MMA) to succinyl-CoA for the Krebs cycle [1]
Methylmalonyl-CoA --[Methylmalonyl-CoA Mutase + Adenosyl-B12]--> Succinyl-CoA- Without B12, methylmalonic acid (MMA) accumulates → elevated serum/urine MMA (a highly specific marker for B12 deficiency — MMA is NOT elevated in folate deficiency, helping to distinguish the two).
- Elevated MMA → abnormal fatty acid synthesis → incorporation of abnormal odd-chain fatty acids into myelin → myelin instability → demyelination → this contributes to subacute combined degeneration of the spinal cord.
- Succinyl-CoA is an intermediate in the Krebs cycle → impaired energy production.
Distinguishing B12 vs Folate Deficiency Biochemically
| Marker | B12 Deficiency | Folate Deficiency |
|---|---|---|
| Serum Homocysteine | ↑ | ↑ |
| Serum MMA | ↑ | Normal |
| Neurological features (SCD) | Yes | No |
MMA is the key distinguishing marker. The classical picture of subacute combined degeneration is confined to B12 deficiency → does NOT occur in folate deficiency [2].
5. Aetiology (with Hong Kong Focus)
| Mechanism | Aetiology | Explanation |
|---|---|---|
| ↓ Intake | Strict vegetarian/vegan | B12 only in animal products |
| Alcoholism | Poor nutrition + GI mucosal damage | |
| Elderly with poor nutrition | Common in Hong Kong nursing home residents | |
| ↓ Gastric Processing | Pernicious anaemia (PA) | Autoimmune destruction of parietal cells → ↓IF secretion + achlorhydria [1][2] |
| H. pylori gastritis | Molecular mimicry — bacteria elicit antibodies that cross-react with gastric parietal H⁺/K⁺-ATPase [1] | |
| Chronic atrophic gastritis (non-autoimmune) | Age-related or H. pylori-related parietal cell loss | |
| Post-gastrectomy / bariatric surgery | Absence of gastric acid and pepsin → impaired liberation of B12 from food proteins; reduced IF production → impaired B12 absorption [1] | |
| ↓ Intestinal Absorption | Terminal ileal disease / resection (Crohn's, TB) | B12-IF complex specifically absorbed in terminal ileum |
| Blind loop syndrome / bacterial overgrowth | Bacteria consume luminal B12 (from small bowel strictures, enterocolonic fistulae, diverticula) [4] | |
| Coeliac disease | Generalized malabsorption | |
| Tropical sprue | Endemic malabsorption — uncommon in HK | |
| Fish tapeworm (Diphyllobothrium latum) | Parasite competes for luminal B12 | |
| Pancreatic insufficiency | ↓Pancreatic proteases → R-binder not degraded → B12 remains bound to R-binder and cannot bind IF | |
| Short gut syndrome | Especially if terminal ileum is lost [4] | |
| Drug-induced | PPIs / H2-blockers / antacids | ↓Gastric acid → impaired dissociation of B12 from food proteins [1] |
| Metformin | ↓B12 absorption in ileum due to effects on Ca²⁺-dependent membrane action (B12-IF complex absorption is calcium-dependent) [1] | |
| Colchicine, cholestyramine, neomycin | Miscellaneous malabsorption | |
| Anti-retroviral agents (e.g., zidovudine) | Can cause macrocytosis (but mechanism differs) | |
| ↑ Demand / Loss | Pregnancy, lactation | ↑Utilization |
| Nitrous oxide (N₂O) exposure | Irreversibly oxidises cobalt ion in B12 → inactivates both B12-dependent enzymes. This is an acute cause of B12 deficiency — important in anaesthetic settings and recreational N₂O abuse ("nangs"). |
This deserves special attention as it is the most commonly tested cause.
- "Pernicious" = harmful / injurious — at the time it was described, PA was truly pernicious as it was associated with continuous worsening of symptoms or even death if untreated [1].
- Pathophysiology: Autoimmune condition that prevents formation of vitamin B12-IF complex → decreases B12 absorption [1]
- Anti-intrinsic factor antibodies (50–70%): Block the binding site on IF → B12 cannot form complex. Insensitive but highly specific (diagnostic if found with B12 deficiency) [2][3].
- Anti-gastric parietal cell antibodies (85–90%): Destroy parietal cells → ↓IF production + achlorhydria. Sensitive but less specific (also present in ~20% of females > 60 years without PA) [2][3].
- Associations:
- Chronic atrophic gastritis — direct consequence of autoimmune attack on gastric mucosa [3][6]
- ↑Risk of gastric carcinoma — due to achlorhydria → ↑microbial colonization, compensatory ↑gastrin → mucosal proliferation [2][3][6]
- Gastric neuroendocrine tumours (carcinoids) — ECL cell hyperplasia driven by hypergastrinaemia [6]
- Polyglandular Autoimmune Syndrome Type 2 (PAS-2) — characterized by autoimmune thyroid disease, adrenal insufficiency (Addison's), T1DM and/or vitiligo [1][5]
- Epidemiology: prevalence 25/100,000 for > 40 years, median age 60 years, F > M [2]
- Risk factors: other organ-specific autoimmune diseases (Hashimoto's, Graves', vitiligo, hypoparathyroidism, Addison's disease), family history of autoimmune disease or pernicious anaemia [2]
Two Gastric Diseases Associated with Pernicious Anaemia
6. Pathophysiology — From Deficiency to Disease
B12 deficiency → impaired DNA synthesis (via folate trap) → nuclear-cytoplasmic maturation asynchrony [7]
- DNA synthesis is slowed but RNA and protein synthesis continue normally → the cytoplasm matures normally while the nucleus lags behind → cells grow larger without dividing → megaloblasts (large, immature erythroid precursors) in the bone marrow.
- This affects ALL rapidly dividing cells, not just erythroid precursors:
- Red cells: Macrocytosis, oval macrocytes (macro-ovalocytes)
- White cells: Hypersegmented neutrophils (> 5 lobes, or any neutrophil with ≥ 6 lobes is diagnostic) [3]
- Platelets: Mild thrombocytopenia
- GI epithelium: Glossitis, oral ulcers, angular stomatitis
- Ineffective erythropoiesis: Many megaloblasts die within the bone marrow before being released → intramedullary haemolysis → ↑unconjugated bilirubin, ↑LDH → mild jaundice, usually a lemon-yellow tint [2]
- Pancytopenia of some degree [3] — because all three cell lineages are affected by the DNA synthesis defect.
Neuropsychiatric features occur in B12 deficiency > folate deficiency, possibly related to ↓methylation of myelin proteins [2]
Two proposed mechanisms:
- ↓SAM (S-adenosylmethionine): B12 deficiency → ↓methionine → ↓SAM → impaired methylation of myelin basic protein and phospholipids → demyelination.
- ↑MMA → abnormal fatty acid incorporation into myelin: Accumulated MMA and propionyl-CoA are incorporated into neuronal lipids in place of normal fatty acids → structurally unstable myelin → demyelination.
The result is demyelination affecting:
- Dorsal columns (DC-ML pathway): proprioception, vibration sense
- Lateral columns (corticospinal tracts): motor function
- Peripheral nerves: sensory and motor neuropathy
- Brain: cognitive dysfunction, psychiatric symptoms
Neurological damage can occur in the absence of haematological changes, as neurons require a higher B12 level to function [2]. This is critical — you cannot rule out B12 deficiency just because the CBC is normal.
Rapidly dividing epithelial cells are also affected by the DNA synthesis defect:
- Oral mucosa: Atrophic glossitis (smooth, beefy-red tongue), angular stomatitis, oral ulcers
- GI mucosa: Malabsorption (can set up a vicious cycle)
- Skin/hair: Skin hyperpigmentation, premature greying of hair (mechanisms not fully understood, likely related to impaired melanin synthesis)
7. Classification
| Stage | Description |
|---|---|
| Stage I — Subclinical | ↓Serum B12/holoTC, ↑homocysteine, ↑MMA; normal CBC, no symptoms |
| Stage II — Haematological | Megaloblastic anaemia develops (↑MCV, oval macrocytes, hypersegmented neutrophils) |
| Stage III — Neurological | Subacute combined degeneration, peripheral neuropathy, cognitive changes |
| Stage IV — Combined | Both haematological and neurological manifestations |
This distinction is critical in clinical practice and frequently tested:
| Feature | Megaloblastic | Non-megaloblastic |
|---|---|---|
| Pathophysiology | Nuclear-cytoplasmic maturation asynchrony | Membrane abnormalities with abnormal cholesterol metabolism |
| Aetiology | B12 deficiency, folate deficiency, drugs (MTX, AZA, imatinib, sunitinib) | Alcoholism (most common), liver disease, hypothyroidism, haemolytic anaemia (reticulocytosis), aplastic anaemia, MDS |
| PBS | Oval macrocytes, hypersegmented neutrophils | Round macrocytes, normal neutrophils |
| Investigations | Active B12 and folate levels, ± RBC folate | Haemolytic screen (LDH, haptoglobin, bilirubin, reticulocyte), LFT, TFT |
High Yield — Severe Macrocytosis
Severe macrocytosis (MCV > 110–115 fL) is almost exclusively associated with megaloblastic anaemia [8]. If you see an MCV > 115, think B12 or folate deficiency first (or drugs like methotrexate/azathioprine). Most non-megaloblastic causes give only mild-to-moderate macrocytosis.
8. Clinical Features
8.1 Symptoms
The clinical presentation is insidious (remember: liver stores last ~3 years), meaning symptoms develop slowly over months to years.
| Symptom | Pathophysiological Basis |
|---|---|
| Fatigue, lethargy | ↓O₂ delivery to tissues → ↓aerobic metabolism |
| Dyspnoea on exertion | Compensatory ↑respiratory rate to improve O₂ exchange |
| Palpitations | Compensatory ↑cardiac output → tachycardia, awareness of heartbeat |
| Dizziness / light-headedness | ↓Cerebral perfusion |
| Exercise intolerance | ↓O₂ delivery to skeletal muscle |
| Angina pectoris (in those with pre-existing IHD) | ↓O₂ delivery to myocardium already compromised by coronary artery disease |
| Symptom | Pathophysiological Basis |
|---|---|
| Paraesthesiae / numbness (bilateral lower limbs, "glove and stocking") | Peripheral neuropathy — demyelination of peripheral nerves; typically starts distally and symmetrically |
| Impaired proprioception and vibration sense (unsteady gait, difficulty walking in dark) | Dorsal column (DC-ML) involvement in subacute combined degeneration (SCD) [2] |
| Limb weakness, stiffness, spasticity | Lateral column (CST) involvement in SCD → UMN signs in lower limbs [2] |
| Unsteady / ataxic gait | Combined dorsal column (sensory ataxia) + corticospinal tract dysfunction |
| Urinary/faecal incontinence (if severe) | Paraparesis ± incontinence if severe [2] — involvement of lateral columns controlling sphincters |
| Visual disturbance | Optic neuropathy (demyelination of optic nerve) — rare |
The neurological picture of SCD is classically: ↑knee jerk (from corticospinal tract/UMN involvement) + ↓ankle jerk (from peripheral neuropathy/LMN involvement) [2]. This dissociation of reflexes is a classic exam finding.
| Symptom | Pathophysiological Basis |
|---|---|
| Depression, irritability | ↓SAM → impaired synthesis of neurotransmitters (serotonin, dopamine, norepinephrine) requiring methylation |
| Cognitive slowing, poor concentration | Demyelination + impaired neurotransmitter synthesis |
| Dementia | Chronic demyelination of cerebral white matter |
| Psychosis | "Megaloblastic madness" — rare but well-described; mechanism unclear, likely multifactorial (↓SAM, demyelination) |
| Symptom | Pathophysiological Basis |
|---|---|
| Sore tongue (glossodynia) | Atrophic glossitis — impaired DNA synthesis in rapidly dividing oral epithelium |
| Oral ulcers | Same mechanism — failure of mucosal regeneration |
| Anorexia, weight loss | Generalized epithelial dysfunction + if underlying cause is malabsorption |
| Diarrhoea | If underlying cause is malabsorption (Crohn's, coeliac, bacterial overgrowth) |
| Symptom | Basis |
|---|---|
| Progressive fatigue | Anaemia + neurological dysfunction |
| Weight loss | Malabsorption (if that's the cause) + anorexia |
8.2 Signs
| Sign | Pathophysiological Basis |
|---|---|
| Pallor (conjunctival, palmar, mucosal) | ↓Haemoglobin → ↓red colouration of vascularised tissues |
| Mild jaundice — lemon-yellow tint [2] | Ineffective erythropoiesis → intramedullary haemolysis of megaloblasts → ↑unconjugated bilirubin. The pallor + jaundice combine to give a characteristic "lemon-yellow" complexion — this is classic for megaloblastic anaemia. |
| Tachycardia | Compensatory ↑cardiac output for ↓O₂ carrying capacity |
| Hyperdynamic circulation (flow murmur, bounding pulse) | High-output state to compensate for anaemia |
| Premature greying of hair [2] | Mechanism uncertain; thought to be autoimmune-related (in pernicious anaemia) or impaired melanin synthesis |
| Skin hyperpigmentation [2] | Mechanism uncertain; may relate to ↑MSH from abnormal POMC processing |
| Sign | Pathophysiological Basis |
|---|---|
| Atrophic glossitis (smooth, beefy-red tongue) [2] | Impaired DNA synthesis → loss of papillae on tongue surface (rapid-turnover epithelium) |
| Angular stomatitis | Impaired epithelial cell renewal at corners of mouth |
| Oral ulceration | Same mechanism |
"Subacute" = develops over weeks to months; "combined" = involves multiple spinal cord columns; "degeneration" = demyelination and axonal loss.
| Sign | Tract Involved | Pathophysiological Basis |
|---|---|---|
| ↓Vibration sense and proprioception (bilateral LL > UL) | Dorsal columns (DC-ML) | Demyelination of dorsal columns → loss of fine touch, vibration, and joint position sense |
| Positive Romberg's sign | Dorsal columns | Loss of proprioceptive input → cannot maintain balance with eyes closed (removing visual compensation for proprioceptive loss) |
| Sensory ataxia (wide-based stamping gait) | Dorsal columns | Loss of proprioception → uncoordinated gait |
| Paraparesis (weakness of both lower limbs) | Lateral columns (CST) | Demyelination of corticospinal tracts → UMN weakness |
| ↑Tone, ↑knee jerks, extensor plantars (UMN signs) | Lateral columns (CST) | Loss of UMN inhibitory control |
| ↓Ankle jerks | Peripheral neuropathy | Concurrent demyelination of peripheral nerves → LMN signs at ankle level |
Classical SCD picture: ↑knee jerk + ↓ankle jerk [2] — this dissociation is pathognomonic and occurs because:
- The UMN lesion (CST involvement) causes hyperreflexia at the knee
- The coexisting peripheral neuropathy causes hyporeflexia at the ankle
- The ankle reflex arc is more distal and thus more affected by the peripheral neuropathy
| Sign | Basis |
|---|---|
| Mild splenomegaly (uncommon) | Extramedullary haematopoiesis in severe cases |
| Hepatomegaly (uncommon) | Extramedullary haematopoiesis or underlying liver disease (if alcoholism is the cause) |
| Sign | Suggests |
|---|---|
| Gastrectomy scar | Post-gastrectomy B12 deficiency |
| Vitiligo | Pernicious anaemia (autoimmune cluster) |
| Thyroid enlargement/disease | Pernicious anaemia + autoimmune thyroid disease |
| Addisonian hyperpigmentation | Pernicious anaemia + Addison's disease |
| Right iliac fossa tenderness/mass | Crohn's disease affecting terminal ileum |
| Signs of chronic liver disease | Alcoholism |
Classic Exam Presentation of B12 Deficiency
An elderly female with:
- Insidious onset fatigue, dyspnoea
- Lemon-yellow complexion (pallor + jaundice)
- Smooth, beefy-red tongue
- Paraesthesiae and unsteady gait
- ↑Knee jerks + ↓ankle jerks
- PBS: oval macrocytes + hypersegmented neutrophils
- FHx or PMHx of autoimmune disease
This is pernicious anaemia until proven otherwise.
Neurology Lecture Slide — High Yield
Vitamin B12 deficiency results in neuropathy / myelopathy and is classified under endocrine/metabolic causes of lower limb weakness in the neurological differential diagnosis framework [9].
9. Important Conceptual Points
Giving folate to a B12-deficient patient will partially correct the megaloblastic anaemia (by bypassing the folate trap — exogenous folate enters the folate cycle downstream). However, it does NOT address the neurological damage, which is driven by ↓SAM and ↑MMA — folate does not participate in these pathways. The danger is that the improving blood counts give a false sense of security while neurological damage silently progresses. Always check B12 before giving folate to any patient with macrocytosis.
B12 deficiency falsely raises serum folate levels [7]. Why? Because B12 is needed to convert methyl-THF → THF inside cells. Without B12, methyl-THF accumulates in the serum (it cannot enter cells efficiently — the "folate trap"). So serum folate appears elevated, but intracellular folate (RBC folate) is low. This is why RBC folate is a more reliable measure of true folate status, especially in B12-deficient patients.
N₂O irreversibly oxidises the cobalt ion in B12 from Co⁺ to Co²⁺/Co³⁺ → renders B12 inactive. This is relevant in two contexts:
- Anaesthesia: Prolonged N₂O exposure during surgery can precipitate acute neurological symptoms in patients with borderline B12 stores.
- Recreational abuse: "Nangs" or "whippets" — increasingly common in young adults. Can cause acute SCD even in patients with normal dietary intake.
Crohn's disease can cause anaemia via haematochezia OR B12 deficiency [10] — because Crohn's characteristically affects the terminal ileum, the specific site of B12 absorption. Ileal resection for Crohn's is a well-known cause of lifelong B12 deficiency requiring parenteral supplementation.
High Yield Summary
Definition: Vitamin B12 (cobalamin) deficiency — inadequate B12 stores → impaired DNA synthesis (megaloblastic anaemia) + demyelination (neurological disease).
Key Biochemistry:
- Methyl-B12 → methionine synthase (homocysteine → methionine; regenerates THF for DNA synthesis; ↓ → ↑homocysteine)
- Adenosyl-B12 → methylmalonyl-CoA mutase (MMA → succinyl-CoA; ↓ → ↑MMA → abnormal myelin)
- MMA distinguishes B12 def from folate def (MMA ↑ only in B12 def)
Causes (SAQ!): Diet (vegan) | Pernicious anaemia (anti-IF, anti-parietal cell Ab) | H. pylori | Post-gastrectomy | Terminal ileal disease/resection | Blind loop syndrome | Fish tapeworm | Drugs (PPI, metformin) | N₂O
PBS: Oval macrocytes + hypersegmented neutrophils (≥ 6 lobes)
Classic Triad: Megaloblastic anaemia + Glossitis + Neuropsychiatric features (SCD)
SCD Pattern: Dorsal columns (↓proprioception/vibration, +Romberg) + Lateral columns (UMN signs) + Peripheral neuropathy. Classic: ↑knee jerk + ↓ankle jerk.
Pernicious Anaemia: Anti-IF Ab (specific, insensitive ~50–70%) + Anti-parietal cell Ab (sensitive, non-specific ~85–90%). Associated with atrophic gastritis, ↑risk gastric CA, PAS-2.
Hong Kong Pearl: Megaloblastic anaemia in HK = B12 deficiency (folate deficiency anaemia essentially does not occur in HK).
Neurological damage can occur WITHOUT anaemia — neurons need higher B12 levels than BM.
Active Recall - Vitamin B12 Deficiency
[1] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf — Section III: Etiology of vitamin B12 deficiency [2] Senior notes: Ryan Ho Haemtology.pdf — Page 29, Pernicious anaemia and B12 deficiency clinical features [3] Senior notes: Block A - Pallor_ diagnosis of anaemia; nutritional anaemia; anaemia of systemic diseases.pdf — Page 19, Laboratory investigations for pernicious anaemia [4] Senior notes: Ryan Ho GI.pdf — Pages 126–127, Short Gut Syndrome and Coeliac Disease [5] Senior notes: Ryan Ho Endocrine.pdf — Page 76, Type 1 DM and autoimmune associations [6] Senior notes: Ryan Ho GI.pdf — Page 75, Autoimmune chronic gastritis [7] Senior notes: Maksim Medicine Notes.pdf — Page 156, Macrocytic anaemia and B12/folate deficiency [8] Senior notes: Ryan Ho Fundamentals.pdf — Page 386, Macrocytosis and macrocytic anaemia [9] Lecture slides: Neurology- Two cases of lower limb weakness.pdf — Pages 18, 21 [10] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf — Page 652, Crohn's disease clinical features
Differential Diagnosis of Vitamin B12 Deficiency
The differential diagnosis (DDx) of vitamin B12 deficiency is best approached from the presenting clinical picture, because patients rarely walk in saying "I have B12 deficiency." Instead, they present with one or more of three overlapping clinical syndromes: (A) macrocytic anaemia, (B) neuropsychiatric disease (myelopathy/neuropathy/cognitive decline), or (C) glossitis and mucocutaneous changes. Each of these presentations has its own differential list that you need to work through to arrive at (or exclude) B12 deficiency as the diagnosis.
Think of it like a funnel: the presenting syndrome generates a broad DDx → laboratory investigations narrow it → specific confirmatory tests clinch the diagnosis.
2. Differential Diagnosis by Presenting Syndrome
2A. Macrocytic Anaemia (MCV > 100 fL)
This is the most common clinical entry point. The first branch-point on the PBS is megaloblastic vs non-megaloblastic [7][8].
| Diagnosis | Key Differentiating Features | Why It Mimics B12 Deficiency |
|---|---|---|
| Vitamin B12 deficiency | Insidious onset; lemon-yellow tint; glossitis; neurological features (SCD); ↑MMA + ↑homocysteine; ↓holoTC | — (this IS the diagnosis) |
| Folate deficiency | More subacute onset; dietary history (alcoholism, poor nutrition); no neurological features (no SCD); ↑homocysteine but normal MMA; ↓serum/RBC folate | Same PBS appearance (oval macrocytes, hypersegmented neutrophils), same megaloblastic BM. Distinguished by MMA (normal in folate def) and absence of SCD. In Hong Kong, folate deficiency anaemia is extremely rare — zero cases in Kwong's study [3]. |
| Drug-induced megaloblastic anaemia | Immunosuppressants (MTX, azathioprine), cytotoxic agents (6-MP, hydroxyurea, capecitabine, cytarabine), TKIs (imatinib, sunitinib), antiretrovirals (zidovudine) [7][8] | These drugs directly impair DNA synthesis (e.g., MTX inhibits dihydrofolate reductase; azathioprine/6-MP inhibit purine synthesis). Easy to exclude — review drug history. |
| Myelodysplastic syndrome (MDS) | Especially in the elderly; often presents with pancytopenia + macrocytosis; PBS shows hypolobulated or hypogranular, dysplastic neutrophils (NOT hypersegmented); may have ring sideroblasts; refractory to B12 replacement [8] | MDS can mimic B12 deficiency with macrocytosis + pancytopenia. Key distinguisher: MDS has dysplastic features (e.g., pseudo-Pelger-Huët neutrophils, dysplastic megakaryocytes), whereas B12 deficiency has hypersegmented neutrophils. Bone marrow examination is needed when lab findings are incompatible with PA, particularly when thinking of MDS, or when the patient does not improve with parenteral B12 [3]. |
High Yield — MCV > 120 fL
A MCV of greater than 120 fL generally only has 2 differential diagnoses: (1) Chemotherapy (very easy to exclude — just ask the patient), and (2) Pernicious anaemia. All other DDx for macrocytosis generally will not be to this magnitude [3]. This is a classic exam pearl.
These are important to distinguish because they have completely different aetiologies and management:
| Diagnosis | Key Differentiating Features | Why It's in the DDx |
|---|---|---|
| Alcohol abuse (most common non-megaloblastic cause) [7] | Social history of alcohol; round macrocytes; normal neutrophils; ↑GGT, ↑MCV (typically < 110); may also have concomitant folate deficiency or liver disease | Alcohol is a direct bone marrow toxin → macrocytosis via altered membrane lipid metabolism. MCV rarely exceeds 110–115. |
| Liver disease | Stigmata of CLD; PBS shows target cells; round macrocytes [8] | Abnormal lipid metabolism → excess cholesterol deposited in RBC membranes → larger cells. |
| Hypothyroidism | Fatigue, weight gain, constipation, dry skin, bradycardia; ↑TSH, ↓fT4 | Reduced metabolic rate → slower cell division → macrocytosis. Also check because hypothyroidism can co-exist with pernicious anaemia in autoimmune polyglandular syndromes [5]. |
| Reticulocytosis (haemolytic anaemia, recovering BM) | ↑Reticulocyte count; haemolytic screen positive (↑LDH, ↑unconjugated bilirubin, ↓haptoglobin); polychromasia on PBS | Reticulocytes are larger than mature RBCs (they still have residual RNA) → ↑MCV. This is a "physiological" macrocytosis — the marrow is working hard, not failing. |
| Multiple myeloma / plasma cell dyscrasia [8] | Elderly; bone pain; ↑ESR; paraprotein on SPEP; Bence Jones proteinuria; lytic lesions | Macrocytosis from unclear mechanism. Also causes rouleaux formation on PBS, which can factitiously elevate MCV. |
| Myelodysplastic syndrome | See above — can present as non-megaloblastic or megaloblastic pattern | Primary marrow disorder with disordered maturation. |
Approach to Macrocytosis — Stepwise
Approach to evaluation [8]:
- Consider factitious causes (RBC clumping, osmotic swelling with hyperglycaemia or prolonged storage, EDTA tube artefact)
- Clinical — age, PMHx, drugs, diet, alcohol
- CBC — severity of macrocytosis (> 110–115 → almost exclusively megaloblastic); additional cytopenias → primary BM problem
- PBS — oval macrocytes + hypersegmented neutrophils = megaloblastic; target cells = liver disease; dysplastic neutrophils = MDS
- Investigations for cause — reticulocyte count, serum B12 and folate (± copper if gastric bypass), TFT, LFT
- BM examination — only when uncertain diagnosis or pancytopenia
2B. Myelopathy / Neuropathy / Neuropsychiatric Symptoms
When a patient presents with progressive lower limb weakness, sensory ataxia, paraesthesiae, or cognitive decline, B12 deficiency enters the DDx of myelopathy and neuropathy. The neurology lecture slides provide an excellent framework [9]:
| Category | Differentials | How to Distinguish from B12 Deficiency |
|---|---|---|
| Vascular | Stroke, spinal cord infarction, epidural haematoma, dural AV fistula [9][11] | Sudden onset (seconds-minutes for infarction); clear vascular territory; MRI spine shows cord signal changes |
| Infective | Epidural abscess (S. aureus), TB spinal osteomyelitis, viral myelitis (HSV, VZV, HIV), HTLV-1, syphilis [9][11] | Fever, systemic infection, raised inflammatory markers; specific patterns on MRI; CSF analysis |
| Neoplastic | Extradural tumours, intramedullary tumours, paraneoplastic syndromes [9] | Progressive course + constitutional symptoms (weight loss, anorexia); MRI shows mass lesion |
| Degenerative | Cervical spondylotic myelopathy (disc prolapse, spondylosis) [9][11] | Very common in elderly; radiculopathy pattern; MRI cervical spine shows canal stenosis/cord compression |
| Inflammatory / Autoimmune | Multiple sclerosis, neuromyelitis optica (NMO) [9][11] | Relapsing-remitting course (MS); optic neuritis + longitudinally extensive transverse myelitis (NMO); MRI brain/spine; CSF oligoclonal bands |
| Congenital | Syringomyelia [9][11] | "Cape-like" dissociated sensory loss (loss of pain/temperature with preserved touch); MRI shows syrinx |
| Endocrine / Metabolic | Vitamin B12 deficiency (SCD), copper deficiency [9] | B12 def: insidious; dorsal + lateral columns; ↑knee jerk + ↓ankle jerk; ↑MMA, ↓holoTC. Copper def: can mimic B12 def exactly (copper is a cofactor in cytochrome c oxidase in myelinated neurons) — check copper if gastric bypass or zinc supplementation |
| Trauma / Toxins | Vertebral fracture; chemotherapy-related neuropathy [9] | Clear temporal relationship to trauma or drug exposure |
Vitamin B12 deficiency resulting in neuropathy / myelopathy is classified under the endocrine/metabolic category in the neurological differential framework [9].
Neurology Lecture Slide — Differential Diagnosis of Myelopathy (High Yield)
Differential Diagnosis of Myelopathy [11]:
- Vascular — epidural haematoma, cord infarction, dural AV fistula
- Infective — epidural abscess, TB spinal osteomyelitis, viral myelitis (HSV, VZV, HIV), chronic infective myelopathy (HTLV-1, syphilis), post-infective/post-immunisation
- Neoplastic — extradural tumours, intramedullary tumours
- Degenerative — spondylosis, disc prolapse
- Inflammatory — RA, ankylosing spondylitis
- Congenital — syringomyelia
- Autoimmune — NMO, multiple sclerosis
- Trauma / toxin — vertebral fracture
- Endocrine — Vitamin B12 deficiency
| Diagnosis | Key Differentiating Features |
|---|---|
| Diabetic neuropathy | Most common cause overall; HbA1c; symmetrical distal sensorimotor; may co-exist with B12 def (metformin use!) |
| Alcoholic neuropathy | Chronic alcohol use; nutritional deficiency (thiamine, B12, folate); painful |
| Drug-induced neuropathy | Temporal relationship — isoniazid (↓B6), chemotherapy (vincristine, cisplatin), antiretrovirals |
| Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) | Proximal AND distal weakness; relapsing course; ↑CSF protein; NCS shows demyelinating pattern |
| Guillain-Barré syndrome | Acute ascending weakness; post-infectious; areflexia; NCS shows demyelinating or axonal pattern |
| Vasculitic neuropathy | Mononeuritis multiplex → confluent; systemic vasculitis features |
| Copper deficiency | Can exactly mimic B12 deficiency; check in patients with gastric bypass or zinc excess |
B12 deficiency is a reversible cause of dementia — one of the few that you must not miss. Workup for dementia routinely includes B12 and folate levels [12]:
| Diagnosis | Key Differentiating Features |
|---|---|
| Alzheimer's disease | Progressive; memory > other domains initially; cortical atrophy on MRI; amyloid/tau biomarkers |
| Vascular dementia | Stepwise decline; vascular risk factors; multi-infarct on MRI |
| Hypothyroidism | ↑TSH; may co-exist with pernicious anaemia |
| Depression (pseudodementia) | Low mood, anhedonia; cognitive deficits improve with treatment |
| Normal pressure hydrocephalus | Triad: gait apraxia, dementia, urinary incontinence; dilated ventricles on CT |
| Neurosyphilis | ↑VDRL; CSF abnormalities |
| B12 deficiency | Reversible; check serum B12/holoTC, MMA; may occur without anaemia |
Investigations for dementia should include CBC, serum B12 and B9, TFT, RFT, Ca, glucose, CT/MRI [12] — this is part of the NICE 2010 minimum investigation set for new-onset dementia.
| Diagnosis | Key Differentiating Features |
|---|---|
| Iron deficiency anaemia | Microcytic; angular stomatitis, koilonychia; pallor without jaundice; ↓ferritin |
| B12 deficiency | Macrocytic; beefy-red smooth tongue (atrophic glossitis); lemon-yellow tint; neurological signs |
| Folate deficiency | Macrocytic; similar oral features to B12 but no neurological signs; ↓folate |
| Riboflavin (B2) deficiency | Angular stomatitis, cheilosis, magenta tongue; not typically with anaemia |
| Niacin (B3) deficiency / Pellagra | 4 Ds: dermatitis, diarrhoea, dementia, death; Casal's necklace; associated with carcinoid syndrome (tryptophan diverted to serotonin → ↓niacin) [13] |
Once B12 deficiency is confirmed, you must identify why the patient is B12-deficient. This is the "second-layer" DDx:
| Cause | Key Clinical Clues | Key Investigations |
|---|---|---|
| Pernicious anaemia (most common medical cause — 95% of cases) [3] | Elderly female; autoimmune disease cluster (thyroid, vitiligo, Addison's); no dietary restriction; insidious | Anti-IF Ab (specific), anti-parietal cell Ab (sensitive); upper endoscopy (atrophic gastritis, screen for gastric CA) [3] |
| Dietary deficiency | Strict vegan/vegetarian; poor nutrition; alcoholism | Dietary history; responds to oral B12 supplementation |
| H. pylori gastritis | Dyspepsia; endemic in HK; molecular mimicry with H⁺/K⁺-ATPase [1] | Urea breath test; stool antigen; endoscopy with biopsy + CLO test |
| Post-gastrectomy / bariatric surgery | Surgical history; ± dumping syndrome | Surgical history is diagnostic |
| Terminal ileal disease (Crohn's, TB) | RIF pain/mass; chronic diarrhoea; steatorrhoea; vitamin B12 deficiency is an extra-intestinal manifestation of Crohn's [10][14] | Ileocolonoscopy; MR enterography; faecal calprotectin |
| Blind loop / bacterial overgrowth | Post-surgical (blind loop, stricture); bloating, steatorrhoea | Hydrogen breath test; response to antibiotics |
| Drug-induced (PPI, metformin) | Chronic PPI use; long-term metformin for T2DM | Drug history; B12 levels improve after dose adjustment or supplementation |
| Fish tapeworm | Raw freshwater fish consumption (uncommon in HK) | Stool ova and parasites |
| Nitrous oxide | Recreational use ("nangs") or recent prolonged anaesthesia | History; acute presentation; functional B12 assays may be normal (B12 is inactivated, not depleted) |
Common Exam Trap
Do NOT assume all macrocytic anaemia is B12 deficiency. The commonest cause of macrocytosis overall is alcohol abuse (non-megaloblastic). The commonest cause of megaloblastic anaemia is B12 deficiency (especially in HK where folate deficiency is vanishingly rare). Always check the PBS first to differentiate megaloblastic from non-megaloblastic.
| Investigation | What It Tells You |
|---|---|
| PBS | Oval macrocytes + hypersegmented neutrophils = megaloblastic; round macrocytes = non-megaloblastic; target cells = liver disease; dysplastic cells = MDS |
| Reticulocyte count | ↑ = haemolysis or BM recovery (non-megaloblastic macrocytosis); ↓ = BM production problem (megaloblastic, MDS, aplastic) |
| Serum holotranscobalamin (active B12) [3] | Low = B12 deficiency; better than total serum B12 |
| Serum and RBC folate | Low = folate deficiency; note B12 def can falsely ↑ serum folate (folate trap) |
| MMA | ↑ in B12 deficiency only, NOT in folate deficiency [1] — key distinguisher |
| Homocysteine | ↑ in BOTH B12 and folate deficiency [1] |
| TFT | Hypothyroidism (non-megaloblastic macrocytosis; also co-exists with PA) |
| LFT | Liver disease (non-megaloblastic macrocytosis) |
| Anti-IF and anti-parietal cell antibodies | For pernicious anaemia |
| BM biopsy | When MDS suspected (pancytopenia + macrocytosis not responding to B12) |
High Yield Summary — Differential Diagnosis
Three clinical entry points for DDx:
- Macrocytic anaemia → megaloblastic (B12 def, folate def, drugs, MDS) vs non-megaloblastic (alcohol, liver, hypothyroid, haemolysis, myeloma)
- Myelopathy / neuropathy → SCD (B12 def), MS, NMO, cord compression, copper deficiency, diabetic neuropathy
- Glossitis / mucocutaneous → B12 def, folate def, iron def, riboflavin def, pellagra
Key distinguishers:
- PBS: oval macrocytes + hypersegmented neutrophils = megaloblastic
- MMA: ↑ in B12 def only (NOT folate def) — the single most specific distinguishing test
- SCD (dorsal + lateral column signs): B12 def only (NOT folate def)
- MCV > 120 fL: essentially only pernicious anaemia or chemotherapy
- HK pearl: folate deficiency anaemia essentially does not exist in HK
Don't miss: MDS can mimic B12 deficiency (pancytopenia + macrocytosis); distinguished by dysplastic (not hypersegmented) neutrophils and failure to respond to B12 replacement → BM biopsy needed.
Active Recall - Differential Diagnosis of B12 Deficiency
References
[1] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf — Section III: Etiology of vitamin B12 deficiency [3] Senior notes: Block A - Pallor_ diagnosis of anaemia; nutritional anaemia; anaemia of systemic diseases.pdf — Pages 18–19, Pernicious anaemia and laboratory investigations [5] Senior notes: Ryan Ho Endocrine.pdf — Page 76, Type 1 DM and autoimmune associations [7] Senior notes: Maksim Medicine Notes.pdf — Page 156, Macrocytic anaemia: megaloblastic vs non-megaloblastic [8] Senior notes: Ryan Ho Fundamentals.pdf — Page 386, Macrocytosis and macrocytic anaemia approach [9] Lecture slides: Neurology- Two cases of lower limb weakness.pdf — Pages 18, 21, 24 (pathological differentials for lower limb weakness) [10] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf — Page 652, Crohn's disease clinical features; Page 665, Extra-intestinal manifestations of IBD [11] Lecture slides: Neurology- Two cases of lower limb weakness.pdf — Page 29, Differential diagnosis of myelopathy [12] Senior notes: Ryan Ho Neurology.pdf — Page 129, Clinical evaluation of dementia [13] Senior notes: Block A - Chronic diarrhoea_ irritable bowel syndrome and inflammatory bowel disease.pdf — Page 5, Carcinoid syndrome and niacin deficiency [14] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf — Page 665, Vitamin B12 deficiency as extra-intestinal manifestation of Crohn's
Diagnostic Criteria, Diagnostic Algorithm and Investigations for Vitamin B12 Deficiency
Unlike many conditions (e.g., SLE, rheumatoid arthritis), vitamin B12 deficiency does not have a single set of formal consensus diagnostic criteria with a sensitivity/specificity score. Instead, the diagnosis is established by integrating clinical features, haematological findings, and biochemical confirmation. Think of it as a three-pillar approach:
| Pillar | What You Need |
|---|---|
| 1. Clinical suspicion | Compatible symptoms/signs: anaemia symptoms, glossitis, neuropsychiatric features (SCD, neuropathy, cognitive decline), lemon-yellow tint |
| 2. Haematological evidence | Macrocytic anaemia (MCV > 100 fL) + PBS: oval macrocytes (macro-ovalocytes) + hypersegmented neutrophils (> 5 lobes, or any neutrophil ≥ 6 lobes) [1][3][15] ± pancytopenia ± low reticulocyte count |
| 3. Biochemical confirmation | Low serum holotranscobalamin (active B12) [3][15] OR low total serum B12 (< 200 pg/mL); supported by ↑MMA ± ↑homocysteine in borderline cases [1] |
Important caveats:
- Neurological manifestations can occur in the absence of haematological changes [2] — a normal CBC does NOT exclude B12 deficiency if clinical suspicion is high. Neurons require a higher B12 level to function than bone marrow cells.
- A borderline serum B12 (200–300 pg/mL) requires metabolite testing (MMA, homocysteine) to confirm or exclude true tissue-level deficiency.
- Once B12 deficiency is confirmed, a second diagnostic step is required: identify the underlying cause (pernicious anaemia, dietary, malabsorption, drugs, etc.).
Practical Diagnostic Rule of Thumb
Confirmed B12 deficiency = Low holotranscobalamin (or low total B12 < 200 pg/mL) + compatible clinical/haematological picture. If total B12 is borderline (200–300 pg/mL), proceed to MMA and homocysteine: if MMA is elevated → B12 deficiency confirmed at the tissue level.
The algorithm moves through three phases: (A) Confirm macrocytic anaemia and establish the megaloblastic pattern; (B) Confirm B12 deficiency biochemically; (C) Identify the underlying cause.
Algorithm explanation, step by step:
Step 1 — Haematological screen:
- Start with CBC + PBS + reticulocyte count [1][2].
- Macrocytic anaemia (MCV > 100 fL), low reticulocyte count, mild leukopenia or thrombocytopenia [1] raise suspicion.
- PBS is the branch-point: oval macrocytes + hypersegmented neutrophils = megaloblastic [3][15]. If round macrocytes with normal neutrophils → non-megaloblastic → different workup entirely.
- Even if CBC is normal, if the patient has neurological symptoms suspicious for SCD, proceed to check B12 anyway.
Step 2 — Biochemical confirmation:
- Serum holotranscobalamin (active B12) is the preferred modern test — it measures the TCII-bound fraction that is actually delivered to tissues [3][15]. In the old days, we measured total serum B12 level, but it does not reflect the active levels [3].
- Serum and RBC folate — to exclude concurrent folate deficiency and to help distinguish B12 from folate deficiency. B12 deficiency can falsely elevate serum folate (folate trap), so RBC folate gives a more accurate picture of intracellular folate status [7].
- If B12 is clearly low (< 200 pg/mL): diagnosis confirmed → proceed to Step 3.
- If B12 is borderline (200–300 pg/mL): Methylmalonic acid (MMA) and homocysteine are NOT routinely needed but reserved for cases in which initial results for vitamin B12 and folate levels are borderline or inconclusive, or if clinical findings are discordant [1].
Step 2b — Metabolite interpretation:
| MMA | Homocysteine | Interpretation |
|---|---|---|
| ↑ | ↑ | B12 deficiency ± concomitant folate deficiency [7][16] |
| Normal | ↑ | Folate deficiency (not B12) [7][16] |
| Normal | Normal | No B12 or folate deficiency [16] |
Why does this work? MMA is elevated in vitamin B12 deficiency but not folate, since vitamin B12 is a cofactor in conversion of methylmalonyl-CoA into succinyl-CoA. Homocysteine is elevated in both vitamin B12 and folate deficiency since both vitamins are required for metabolism of homocysteine into methionine [1].
Step 3 — Identify the cause:
- Autoantibodies for pernicious anaemia
- Detailed dietary and drug history
- GI evaluation if malabsorption is suspected
3. Investigation Modalities — Detailed Breakdown
3A. Haematological Investigations
| Parameter | Expected Finding | Interpretation |
|---|---|---|
| Haemoglobin | ↓ (can be severely low, e.g., 40–60 g/L in severe PA) | Anaemia from impaired erythropoiesis |
| MCV | > 100 fL (typically 110–130 fL in PA; > 120 fL essentially = PA or chemotherapy [3]) | Macrocytosis from nuclear-cytoplasmic asynchrony → cells grow without dividing |
| MCH | ↑ (hyperchromic) | More haemoglobin per cell because cells are larger |
| WBC | Mild leukopenia [1] | DNA synthesis defect affects all rapidly dividing cells, including granulocyte precursors |
| Platelets | Mild thrombocytopenia [1] | Same mechanism — megakaryocytes also affected |
| Reticulocyte count | Low [1] | Inappropriately low for the degree of anaemia → the marrow is failing to produce, not that cells are being destroyed peripherally. This helps distinguish from haemolytic anaemia (which would have ↑reticulocytes). |
GC Lecture Slide — High Yield
Megaloblastic anaemia PBS findings [15]:
- Red cells are macrocytic (generally > 100 fL)
- Red cells are oval in shape → oval macrocytes
- Hypersegmented neutrophil → diagnostic, more than 6 segments
- Have some small degree of pancytopenia
This is arguably the single most important investigation because it tells you the morphological pattern before any biochemistry comes back:
| Finding | Description | Pathophysiological Basis |
|---|---|---|
| Oval macrocytes (macro-ovalocytes) [1][2][3][15] | RBCs are larger than normal AND oval/elliptical in shape | Nuclear-cytoplasmic asynchrony → cells enlarge without successful mitosis; the oval shape reflects altered membrane dynamics during abnormal erythropoiesis |
| Hypersegmented neutrophils [1][2][3][15] | Neutrophils with > 5 lobes (or any with ≥ 6 lobes = diagnostic) | Impaired DNA synthesis → neutrophils undergo extra nuclear lobulation before they can successfully divide. This is a hallmark of megaloblastic anaemia — you essentially cannot see this in non-megaloblastic causes. |
| Anisocytosis and poikilocytosis | Variation in RBC size and shape | Disordered erythropoiesis |
| Howell-Jolly bodies (occasionally) | Nuclear remnants in RBCs | Failure of normal nuclear extrusion |
| No polychromasia | Absence of bluish-staining reticulocytes | Low reticulocyte response — the marrow is failing |
Exam pearl: If the PBS shows hypersegmented neutrophils + oval macrocytes, this is megaloblastic anaemia. The next question is B12 or folate? → check B12, folate, and if needed, MMA.
- Low or inappropriately normal [1] — this is crucial because it establishes that the anaemia is hypoproliferative (production problem) rather than haemolytic (destruction problem).
- In haemolytic anaemia, the reticulocyte count would be elevated (the marrow is working overtime to compensate for peripheral destruction).
- In B12 deficiency, the problem is in the bone marrow itself (ineffective erythropoiesis) → the marrow cannot produce adequate mature RBCs → low reticulocyte output.
3B. Biochemical Investigations — Confirming B12 Deficiency
| Parameter | Value | Interpretation |
|---|---|---|
| Normal | > 300 pg/mL (> 221 pmol/L) | B12 deficiency unlikely |
| Borderline | 200–300 pg/mL | Indeterminate — need metabolite testing (MMA ± homocysteine) [2] |
| Deficient | < 200 pg/mL (< 148 pmol/L) | B12 deficiency likely [2] |
Limitations of total serum B12:
- Measures BOTH active (TCII-bound, 10–30%) and inactive (haptocorrin-bound, 70–90%) fractions.
- In CML/MPN, haptocorrin (TCIII) is overproduced → total B12 is falsely elevated [3].
- Conversely, in pregnancy or OCP use, total B12 may be falsely low.
- The TCII bound to Vit B12 = active fraction = what we use nowadays [3][15].
- This is the fraction that is actually taken up by tissues via the TCII receptor.
- More sensitive and specific than total B12 for detecting true tissue deficiency.
- Low holotranscobalamin (< 35 pmol/L) = B12 deficiency confirmed.
GC 076 Lecture slide: "Serum holotranscobalamin" is listed as one of the laboratory investigations for patients with suspected pernicious anaemia [15].
- Serum folate: Reflects recent dietary intake (can fluctuate with a single folate-containing meal). Normal level > 4 ng/mL suggests folate is not deficient unless the individual has recently consumed a folate-containing meal or supplement [1].
- RBC folate: Reflects folate status over the preceding 3 months (lifespan of the RBC). RBC folate < 150 ng/mL indicates prolonged deficiency [2]. More reliable but more expensive.
- B12 deficiency falsely elevates serum folate levels [7] — because B12 is needed to "release" methyl-THF from its trapped form inside cells. Without B12, methyl-THF accumulates in serum → serum folate appears high even though intracellular folate is functionally depleted.
Why Check Folate at All?
You check folate to: (1) exclude folate deficiency as the cause of megaloblastic anaemia, and (2) detect concurrent folate deficiency. Remember that RBC folate can be obtained but is not routinely needed because it does not provide additional information and is more costly [1] — it's reserved for when serum folate is confounded by recent diet.
NOT routinely needed but reserved for borderline or inconclusive cases [1]:
| Metabolite | In B12 Deficiency | In Folate Deficiency | Mechanism |
|---|---|---|---|
| MMA | ↑↑ | Normal | B12 (as adenosylcobalamin) is cofactor for methylmalonyl-CoA mutase (MMA → succinyl-CoA). Without B12, MMA accumulates. [1] |
| Homocysteine | ↑ | ↑ | Both B12 and folate are needed for methionine synthase (homocysteine → methionine). Deficiency of either → homocysteine accumulates. [1] |
Interpretation matrix [7][16]:
| MMA | Homocysteine | Diagnosis |
|---|---|---|
| ↑ | ↑ | B12 deficiency ± folate deficiency |
| Normal | ↑ | Folate deficiency (not B12) |
| Normal | Normal | No B12/folate deficiency |
| ↑ | Normal | Rare — consider renal failure (MMA accumulates), or very early B12 deficiency |
Caveats:
- MMA can be falsely elevated in renal failure (reduced clearance) and in rare inborn errors of metabolism (methylmalonic aciduria).
- Homocysteine can be elevated by renal failure, hypothyroidism, B6 deficiency, and genetic causes (e.g., MTHFR polymorphisms).
This is a unique feature of B12 deficiency — the megaloblasts that form in the bone marrow are fragile and many die before being released into circulation. This is called ineffective erythropoiesis or intramedullary haemolysis. It produces a biochemical picture that resembles haemolysis:
| Marker | Expected Finding | Explanation |
|---|---|---|
| ↑ LDH | Often markedly elevated | Released from dying megaloblasts in the bone marrow. LDH can be extremely high in severe megaloblastic anaemia — sometimes mimicking malignancy or thrombotic microangiopathy. [1][2] |
| ↑ Unconjugated (indirect) bilirubin | Mild elevation | Haemoglobin from destroyed megaloblasts is metabolised to unconjugated bilirubin → gives the characteristic lemon-yellow tint [2] |
| ↓ Haptoglobin | Low | Free Hb binds to haptoglobin → the Hb-haptoglobin complex is rapidly removed by the liver → reduction in plasma haptoglobin [1] |
| ↑ AST | Mild elevation | Released from destroyed erythroid precursors [1] |
Common Exam Trap
Elevated LDH + unconjugated bilirubin + low haptoglobin in megaloblastic anaemia can be mistaken for haemolytic anaemia. The key distinguisher is the reticulocyte count: in haemolytic anaemia, reticulocytes are HIGH (the marrow is compensating); in megaloblastic anaemia, reticulocytes are LOW (the marrow is failing — the destruction is happening INSIDE the marrow, not in the periphery).
3D. Investigations for Pernicious Anaemia (Identifying the Cause)
GC 076 Lecture slide [15]: "Anti-parietal cell antibody – Sensitive but less specific, also detectable in small proportion of normal individuals" "Anti-intrinsic factor antibody – Specific but less sensitive, some patients with PA may be negative"
| Antibody | Sensitivity | Specificity | Clinical Utility |
|---|---|---|---|
| Anti-intrinsic factor (IF) antibody | Low (50–70%) | High (diagnostic if positive in setting of B12 deficiency) [2][3][15] | If positive → confirms PA. If negative → does NOT exclude PA (many PA patients are anti-IF negative). |
| Anti-parietal cell antibody | High (85–90%) | Low (also present in ~20% of healthy females > 60 years) [2][3][15] | Supports the diagnosis but cannot confirm it alone. Also found in chronic atrophic gastritis without PA. |
Why two antibodies? The two antibodies target different components of the same system:
- Anti-IF Ab directly blocks B12-IF complex formation → functionally relevant → hence highly specific.
- Anti-parietal cell Ab targets the H⁺/K⁺-ATPase (proton pump) on parietal cells → destroys the cells that make IF and acid → hence more sensitive (almost all PA patients have parietal cell damage) but less specific (parietal cells can be damaged by many things).
GC 076 Lecture slide [15]: "Upper endoscopy – Atrophic gastritis and carcinoma of stomach"
| Finding | Significance |
|---|---|
| Atrophic gastritis | Common complication of PA — autoimmune attack on stomach [3][15]. Shows pale, thinned mucosa with loss of rugal folds in the gastric body/fundus. |
| Carcinoma of stomach | Notably associated with PA — achlorhydria → ↑microbial colonization + compensatory ↑gastrin → mucosal proliferation → ↑risk of gastric adenocarcinoma and neuroendocrine (carcinoid) tumours [2][3][15]. |
Endoscopy with biopsy serves a dual purpose: (1) histological confirmation of atrophic gastritis, and (2) screening for gastric malignancy. Current guidelines recommend initial endoscopy at diagnosis of PA, though surveillance protocols vary.
GC 076 Lecture slide [15]: "Schilling test – historical interests, obsolete in HK"
- Old test that measured how well the body absorbs B12 using radioactive-labelled B12, then measuring urinary excretion [3]. Performed in two stages (without and with exogenous IF) to differentiate IF deficiency from ileal malabsorption.
- Don't use anymore since we have the antibodies [3] — autoantibody testing has replaced it entirely.
- Mentioned only for completeness and because it occasionally appears in MCQ stems asking about "historical" tests.
GC 076 Lecture slide [15]: "Bone Marrow Examination – Not routinely needed, except when laboratory findings incompatible with PA"
| Indication | Rationale |
|---|---|
| Lab findings incompatible with PA | When you are thinking of MDS (which can also cause pancytopenia with macrocytosis) [3] |
| No improvement with parenteral B12 | Patient does not respond to replacement → MDS or other primary BM disorder must be excluded [3] |
| Diagnostic uncertainty | Unexplained pancytopenia where the clinical picture is ambiguous |
BM findings in megaloblastic anaemia (if performed):
- Hypercellular marrow (paradoxically — the marrow is working hard but producing defective cells)
- Megaloblastic erythropoiesis: Giant, immature erythroid precursors (megaloblasts) with open, lacy chromatin and asynchronous nuclear-cytoplasmic maturation
- Giant metamyelocytes and band forms: Granulocyte precursors are also enlarged
- ↑Iron stores: Iron is available but cannot be effectively incorporated (contrast with iron deficiency where stores are depleted)
| Investigation | Indication | What It Shows |
|---|---|---|
| Dietary history | All patients | Strict vegan/vegetarian; alcoholism; elderly with poor nutrition |
| Drug history | All patients | PPI/H2-blocker use; metformin; immunosuppressants |
| H. pylori testing (urea breath test, stool antigen, or endoscopic CLO test) | If dyspepsia, or to explain parietal cell damage | H. pylori → molecular mimicry with H⁺/K⁺-ATPase → parietal cell damage |
| Ileocolonoscopy / MR enterography | Suspected Crohn's disease or terminal ileal disease | Terminal ileal inflammation/stricture → B12 malabsorption |
| Faecal calprotectin | Suspected IBD | Elevated in intestinal inflammation |
| Hydrogen breath test | Suspected bacterial overgrowth (blind loop syndrome) | Positive = bacterial overgrowth consuming B12 |
| Stool ova and parasites | Fish tapeworm (rare in HK) | Diphyllobothrium latum eggs/proglottids |
| TFT | Screen for co-existing autoimmune thyroid disease in PA | Hypothyroidism is the most commonly associated autoimmune condition |
| Serum gastrin | Suspected PA with atrophic gastritis | Markedly elevated (loss of parietal cells → loss of acid → ↓negative feedback on G-cells → ↑gastrin) |
| Phase | Investigation | Key Finding | Clinical Significance |
|---|---|---|---|
| Screen | CBC | MCV > 100 fL; ↓Hb; mild ↓WBC, ↓Plt; ↓reticulocytes | Macrocytic anaemia with hypoproliferative response |
| Screen | PBS | Oval macrocytes + hypersegmented neutrophils (≥ 6 lobes) | Diagnostic pattern for megaloblastic anaemia |
| Confirm | Serum holotranscobalamin | Low (< 35 pmol/L) | Active B12 deficiency confirmed |
| Confirm | Serum B12 (total) | < 200 pg/mL = deficient; 200–300 = borderline | Less accurate than holoTC (includes inactive haptocorrin-bound fraction) |
| Confirm | Serum/RBC folate | Normal or elevated (folate trap) | Excludes folate deficiency; falsely ↑serum folate expected in B12 def |
| Confirm (if borderline) | MMA | ↑ (specific to B12 def) | Distinguishes B12 from folate deficiency |
| Confirm (if borderline) | Homocysteine | ↑ (in both B12 and folate def) | Non-specific but supports deficiency |
| Haemolysis markers | LDH, unconj. bilirubin, haptoglobin, AST | ↑LDH, ↑bilirubin, ↓haptoglobin, ↑AST | Intramedullary haemolysis (ineffective erythropoiesis) |
| Cause — PA | Anti-IF Ab | Positive in 50–70% | Specific — diagnostic if positive |
| Cause — PA | Anti-parietal cell Ab | Positive in 85–90% | Sensitive but non-specific |
| Cause — PA | Upper endoscopy | Atrophic gastritis; gastric CA screening | Essential in confirmed PA |
| Cause — Other | Dietary/drug Hx, H. pylori testing, ileocolonoscopy, H2 breath test | As per clinical suspicion | Identify reversible causes |
| If uncertain | BM examination | Megaloblastic erythropoiesis; excludes MDS | Only if incompatible with PA or no response to B12 |
High Yield Summary — Diagnosis of B12 Deficiency
Three-pillar diagnosis:
- Clinical suspicion (anaemia, glossitis, SCD, neuropsychiatric)
- Haematological evidence (macrocytosis + oval macrocytes + hypersegmented neutrophils + pancytopenia)
- Biochemical confirmation (↓holotranscobalamin; ↑MMA for borderline cases)
GC 076 Lecture slide investigations for suspected PA:
- Serum Vitamin B12 level
- Serum holotranscobalamin (preferred modern test)
- Serum and red cell folate level
- Anti-parietal cell Ab — sensitive, less specific
- Anti-IF Ab — specific, less sensitive
- Upper endoscopy — atrophic gastritis + CA stomach screening
- Schilling test — historical, obsolete in HK
- BM Examination — not routinely needed, except when incompatible with PA
Key metabolite interpretation:
- ↑MMA + ↑Hcy = B12 deficiency
- Normal MMA + ↑Hcy = Folate deficiency
- Both normal = Neither deficiency
Don't forget: Intramedullary haemolysis gives ↑LDH, ↑bilirubin, ↓haptoglobin — mimics haemolysis, but reticulocytes are LOW (not high).
MCV > 120 fL = pernicious anaemia or chemotherapy — nothing else reliably gets this high.
Active Recall - Diagnosis of B12 Deficiency
References
[1] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf — Section V: Diagnosis of vitamin B12 deficiency [2] Senior notes: Ryan Ho Haemtology.pdf — Page 29, Diagnostic evaluation of B12 deficiency and pernicious anaemia [3] Senior notes: Block A - Pallor_ diagnosis of anaemia; nutritional anaemia; anaemia of systemic diseases.pdf — Pages 18–19, Laboratory investigations for pernicious anaemia [7] Senior notes: Maksim Medicine Notes.pdf — Pages 156–158, Macrocytic anaemia and B12/folate deficiency [15] Lecture slides: GC 076. Pallor_diagnosis of anaemia; nutritional anaemia; anaemia of systemic diseases.pdf — Page 27, Laboratory investigations for suspected pernicious anaemia [16] Senior notes: Maksim Medicine Notes.pdf — Page 157, Metabolite testing interpretation for B12 vs folate deficiency
Management of Vitamin B12 Deficiency
Before diving into specific regimens, let's establish the overarching logic. The management of B12 deficiency rests on four pillars:
| Pillar | Explanation |
|---|---|
| 1. Replace B12 | The core treatment — replenish stores and correct the biochemical defect |
| 2. Choose the correct route | Parenteral (IM/SC) vs oral — depends on the underlying cause (malabsorption vs dietary) |
| 3. Treat the underlying cause | If reversible (e.g., stop offending drug, treat H. pylori, dietary modification) |
| 4. Monitor for response and complications of treatment | Haematological response, neurological recovery, and watch for hypokalaemia and iron depletion during the reticulocyte surge |
Key concept — why route matters:
The entire point of B12 absorption physiology is that it requires intrinsic factor + terminal ileal cubilin receptor + calcium. If the cause of deficiency is a failure of this pathway (pernicious anaemia, gastrectomy, ileal disease), then giving B12 by mouth at normal doses is futile — it cannot be absorbed. In patients who have vitamin B12 deficiency due to medical or surgical reasons, normally cannot do oral, since there are issues with intrinsic factor production / B12-IF complex absorption → so parenteral [3]. However, at supraphysiological oral doses (≥ 1000 μg/day), ~1% can be absorbed via passive diffusion independent of IF [2][3], which we will discuss below.
3. Treatment Modalities — Detailed
3A. Vitamin B12 (Cobalamin) Replacement
This is the most commonly tested management decision:
| Factor | Parenteral (IM or SC) | Oral (high-dose PO) |
|---|---|---|
| When to use | Medical or surgical causes of B12 deficiency (PA, gastrectomy, ileal disease, malabsorption) [3] | Dietary deficiency (vegan, poor nutrition, mild drug-induced) [2] |
| Mechanism | Bypasses the GI tract entirely → 100% bioavailable | At standard doses (5–10 μg), absorption depends on IF/ileum. At supraphysiological doses (1000 μg), ~1% is absorbed via passive diffusion — independent of IF and ileum [2][3] |
| Dose | 1000 μg IM, loading then maintenance | 1000 μg PO daily [2] |
| Advantages | Reliable absorption; proven efficacy; guaranteed compliance (healthcare-administered) | Convenient; non-invasive; avoids injection-related complications |
| Disadvantages | Requires clinic visits; painful; risk of haematoma in pancytopenic patients | Requires adherence to daily dosing; less reliable absorption if malabsorption is severe |
IM is the standard route [3]:
| Phase | Regimen | Rationale |
|---|---|---|
| Loading | 1000 μg IM every other day (or weekly) for 2 weeks (typical: 6 doses) — or in neurological involvement: every other day for up to 3 weeks | Rapidly replenish depleted stores; higher frequency in neurological cases because neurons are more vulnerable and need rapid correction |
| Maintenance | 1000 μg IM every 1–3 months (commonly every 2 months) [2] | Maintain adequate stores long-term; frequency depends on underlying cause |
Why IM and not IV? IV → possible that all the B12 will go into the urine, wasted and not a sustained-release deposit. Need something more sustainable → the standard is intramuscular [3]. IM injection creates a depot in the muscle from which B12 is slowly released into the bloodstream over weeks.
When to use subcutaneous instead of IM: In patients with profound PA, they will have pancytopenia → you would hesitate to use IM since you might cause haematoma. Therefore, give subcutaneous in these cases [3]. SC injection avoids the deep muscle compartment where bleeding into a confined space could be dangerous in thrombocytopenic patients.
GC Lecture High Yield — Route of B12 Replacement
For medical or surgical causes → parenteral (IM standard; SC if pancytopenic) [3] For dietary causes → oral (1000 μg daily) [2] New evidence: superhuman oral doses (1000 μg daily, ~10× the normal dose) may achieve adequate absorption even in malabsorption via passive diffusion [3] — though the practical question is whether you want to commit a patient to this regimen daily. Parenteral remains the standard for PA.
| Phase | Regimen | Notes |
|---|---|---|
| Replacement | 1000 μg PO daily [2] | ~10× the typical dietary intake; relies on ~1% passive diffusion |
| Duration | Until deficiency corrected (if cause is reversible) OR lifelong (if strict vegan diet with no intent to change) | Vegans require lifelong supplementation because no plant foods contain B12 |
Oral B12 can also be tried even if impaired absorption — will be absorbed via non-IF/terminal ileum-dependent mechanisms, e.g., diffusion [2]. This is an evolving area — some guidelines now accept high-dose oral as an alternative to IM even in PA, though adherence is the main concern.
| Form | Description |
|---|---|
| Cyanocobalamin | Most commonly used; synthetic; must be converted to active forms (methyl- and adenosylcobalamin) in the body; stable and inexpensive |
| Hydroxocobalamin | Preferred in many centres (including UK/HK); longer-lasting depot when given IM; also used as antidote for cyanide poisoning |
| Methylcobalamin / Adenosylcobalamin | Active forms; used in some supplements; no proven clinical advantage over cyanocobalamin/hydroxocobalamin |
Folate with B12 if B12 status unknown, e.g., urgent treatment needed while awaiting B12/folate result [2] Use of folate alone in the presence of vitamin B12 deficiency may cause worsening of neurological deficit despite partially masking its haematological deficits [2]
This is a critical safety principle:
- Why give folate with B12? In an emergency (e.g., severely anaemic patient, neurological symptoms) you may need to start replacement before B12/folate results return. Giving both covers all bases.
- Why NEVER give folate alone? Folate bypasses the "folate trap" and restores DNA synthesis → the megaloblastic anaemia improves (CBC looks better). BUT folate does nothing for the neurological damage (which depends on methylation via SAM and MMA pathways, both B12-dependent). The improving blood counts create a false sense of security while the spinal cord continues to demyelinate. This is one of the most dangerous pitfalls in haematology.
Do NOT Give Folate Alone
Giving folate alone in undiagnosed B12 deficiency will partially correct the anaemia (masking the haematological picture) while worsening the neurological deficit. Always check B12 status before starting folate. If urgent treatment is needed and results are pending, give BOTH B12 and folate together.
| Cause | Specific Management |
|---|---|
| Dietary deficiency (vegan/vegetarian) | Dietary counselling: encourage fortified cereals, nutritional yeast, B12-fortified soy products, or consider dairy/eggs if lacto-ovo-vegetarian. Lifelong oral B12 supplementation if strict vegan. |
| Pernicious anaemia | Lifelong parenteral B12 (the autoimmune destruction of parietal cells is permanent and irreversible). Screen for associated autoimmune conditions (TFT for thyroid disease, glucose for T1DM). Upper endoscopy for atrophic gastritis and gastric CA screening [3][15]. |
| Post-gastrectomy / bariatric surgery | Lifelong parenteral B12 — loss of parietal cells and acid is permanent. Start replacement prophylactically soon after surgery (deficiency will manifest in 1–2 years once stores are exhausted [3]). |
| Terminal ileal disease (Crohn's) | Treat underlying Crohn's disease; if terminal ileum is resected, lifelong parenteral B12. If inflammation is controlled and ileum is intact, may trial oral. |
| Drug-induced (PPI, metformin) | Review drug necessity. If PPI can be stopped or stepped down, do so. For metformin — risk/benefit assessment; metformin is often essential for diabetes control, so monitor B12 annually and supplement as needed (oral B12 supplementation usually adequate since the metformin effect is partial, not complete). |
| H. pylori gastritis | Eradication therapy (PPI-based triple or quadruple therapy). May reverse the gastric damage if caught early. |
| Bacterial overgrowth (blind loop) | Antibiotics (e.g., rifaximin, metronidazole, ciprofloxacin) to reduce bacterial load; surgical correction if anatomical cause. |
| Fish tapeworm | Antihelminthic treatment (praziquantel or niclosamide). |
| Nitrous oxide abuse | Cessation of N₂O use + parenteral B12 replacement. B12 must be given parenterally because the mechanism is inactivation (not depletion) — oral B12 would just be inactivated too if N₂O exposure continues. |
| Measure | Rationale |
|---|---|
| Blood transfusion | Only in severe symptomatic anaemia (Hb < 70–80 g/L) or haemodynamic instability [2]. Transfuse slowly and cautiously — chronically anaemic patients have expanded plasma volume and are at risk of transfusion-associated circulatory overload (TACO). Use 1 unit at a time with furosemide if needed. |
| Potassium monitoring | During the reticulocyte surge (days 5–10), rapidly dividing cells shift potassium intracellularly → hypokalaemia [2]. Monitor K⁺ and supplement if needed. This can be life-threatening if unrecognised. |
| Iron supplementation | Rapid erythropoiesis depletes iron stores → may develop iron deficiency anaemia as B12 deficiency corrects → dimorphic red cells on PBS (a mixture of small microcytic iron-deficient cells and large macrocytic B12-deficient cells) [2]. Check ferritin and iron profile; supplement iron if required. |
| Screening for associated conditions | In pernicious anaemia: TFT (thyroid disease), glucose (T1DM), cortisol (Addison's). Screen family members for autoimmune disease. |
4. Monitoring Response to Treatment
| Timepoint | Expected Response | What to Look For |
|---|---|---|
| Days 3–5 | Subjective improvement in well-being | Patient reports feeling better (even before blood counts change) |
| Days 5–10 | Reticulocyte count peaks [2] | This is the earliest objective sign that the marrow is responding. If reticulocytes don't rise by day 10, question the diagnosis (? MDS, ? wrong diagnosis). |
| Weeks 2–4 | Hb rises by ~1 g/dL per week [2] | Gradual normalisation of Hb |
| 6–8 weeks | MCV normalises; hypersegmented neutrophils disappear | PBS returns to normal |
| 2–3 months | B12 level normalised | Confirm biochemical correction |
| Ongoing | CBC every 3–6 months initially, then annually | Ensure maintenance replacement is adequate |
| Timeline | Expected Response |
|---|---|
| Weeks to months | Paraesthesiae may begin to improve |
| 6–12 months | Sensory neuropathy takes 6–12 months to correct [2] |
| Variable | Some neurological deficits (especially motor/SCD) may not fully improve if treatment was delayed [2] — this is why early diagnosis matters |
| Irreversible | Longstanding SCD with established axonal loss (not just demyelination) may leave permanent deficits |
Key Clinical Point — Irreversibility
Haematological abnormalities are always reversible with adequate B12 replacement. Neurological damage is sometimes irreversible — particularly if treatment is delayed beyond 6 months of symptom onset or if there is established axonal loss. This underscores why B12 deficiency must be diagnosed and treated promptly, and why neurological symptoms should trigger urgent replacement.
| Complication | Mechanism | Prevention/Management |
|---|---|---|
| Hypokalaemia | Reticulocyte surge → rapid cell division → K⁺ shifts intracellularly | Monitor K⁺ during first 1–2 weeks; supplement if < 3.5 mmol/L |
| Iron deficiency | Rapid erythropoiesis depletes iron stores; dimorphic red cells on PBS [2] | Check ferritin; supplement iron if needed |
| Fluid overload from transfusion | Chronically anaemic patients have expanded plasma volume → at risk of TACO | Transfuse slowly (1 unit over 3–4 hours); give furosemide with each unit |
| Injection site complications | IM haematoma (especially in thrombocytopenic patients) | Use SC route if profound pancytopenia [3] |
| Situation | Management Approach |
|---|---|
| Pregnancy | Urgent replacement — B12 deficiency can cause neural tube defects and developmental delay. Parenteral B12 is safe in pregnancy. Give concurrent folic acid (standard antenatal dose 400–800 μg/day). |
| Neonates/infants of B12-deficient mothers | May present with failure to thrive, developmental delay, megaloblastic anaemia. Urgent IM B12 replacement. |
| Patients on long-term metformin | Screen B12 levels periodically (annually or every 2–3 years). Supplement with oral B12 (1000 μg/day) if deficient. Usually do NOT need to stop metformin (risk-benefit favours continuing metformin for diabetes). |
| Patients on long-term PPIs | Similar to metformin — periodic screening and oral supplementation if deficient. Consider PPI deprescription if no ongoing indication. |
| Nitrous oxide exposure | Stop N₂O immediately. Give parenteral B12 (IM hydroxocobalamin). Standard oral B12 is insufficient because ongoing N₂O exposure inactivates absorbed B12. |
| Post-gastrectomy (prophylactic) | Start IM B12 replacement prophylactically after total gastrectomy. Deficiency is inevitable — stores last ~1–2 years but early replacement prevents symptomatic deficiency. |
| Scenario | Route | Regimen | Duration |
|---|---|---|---|
| PA / gastrectomy / ileal resection | IM (SC if pancytopenic) | 1000 μg IM loading (every other day or weekly × 2 weeks), then 1000 μg IM every 1–3 months | Lifelong |
| Dietary deficiency (vegan) | Oral | 1000 μg PO daily | Lifelong if remaining vegan |
| Drug-induced (PPI, metformin) | Oral | 1000 μg PO daily ± drug review | Until corrected; ongoing monitoring |
| Neurological involvement (any cause) | IM (urgent) | 1000 μg IM every other day for 3 weeks, then 1000 μg IM every 2 months | Lifelong if cause is irreversible |
| Urgent / awaiting results | IM | B12 1000 μg IM + folic acid 5 mg PO daily | Until diagnosis clarified |
High Yield Summary — Management of B12 Deficiency
Route decision:
- Medical/surgical cause (PA, gastrectomy, ileal disease) → parenteral (IM standard, SC if pancytopenic)
- Dietary cause → oral (1000 μg/day)
- New evidence: high-dose oral (1000 μg) can work even in malabsorption via passive diffusion, but IM remains standard
Critical safety rule: NEVER give folate alone if B12 status is unknown — it will mask the anaemia while worsening neurological damage. If urgent, give BOTH B12 + folate.
Monitoring response:
- Reticulocyte peak: days 5–10
- Hb rises ~1 g/dL per week
- Watch for hypokalaemia and iron depletion during reticulocyte surge
- Neurological recovery: 6–12 months for sensory; motor/SCD may be irreversible if delayed
Lifelong replacement: PA, post-gastrectomy, ileal resection, strict vegans
Pernicious anaemia additionally requires: Upper endoscopy (atrophic gastritis + gastric CA screening); screening for autoimmune comorbidities (thyroid, T1DM, Addison's)
Active Recall - Management of B12 Deficiency
References
[1] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf — Section V: Diagnosis of vitamin B12 deficiency [2] Senior notes: Ryan Ho Haemtology.pdf — Page 30, Management of B12 and folate deficiency [3] Senior notes: Block A - Pallor_ diagnosis of anaemia; nutritional anaemia; anaemia of systemic diseases.pdf — Pages 16, 18–20, B12 absorption, clinical presentation, and replacement route [15] Lecture slides: GC 076. Pallor_diagnosis of anaemia; nutritional anaemia; anaemia of systemic diseases.pdf — Page 27, Laboratory investigations for suspected pernicious anaemia
Complications of Vitamin B12 Deficiency
The complications of B12 deficiency span multiple organ systems. This makes sense when you recall the two fundamental biochemical defects: (1) impaired DNA synthesis (affecting all rapidly dividing cells) and (2) impaired methylation and abnormal fatty acid incorporation into myelin (affecting the nervous system). We can organise complications into those arising from the disease itself (untreated/undertreated B12 deficiency), those arising from the underlying cause (especially pernicious anaemia), and those arising from treatment.
1. Complications of B12 Deficiency Itself
| Complication | Mechanism | Clinical Significance |
|---|---|---|
| Severe pancytopenia | DNA synthesis defect affects all three cell lineages (RBCs, WBCs, platelets). Pancytopenia — all cells require B12 [3]. | Severe anaemia → heart failure, angina; leukopenia → infection susceptibility; thrombocytopenia → bleeding tendency. Can mimic aplastic anaemia or MDS on initial presentation. |
| Severe symptomatic anaemia | Progressive ↓Hb from ineffective erythropoiesis. Can reach dangerously low levels (Hb 30–50 g/L) because onset is so insidious that cardiovascular compensation masks symptoms until very late. | May present with high-output cardiac failure (tachycardia, bounding pulse, peripheral oedema, dyspnoea at rest). Elderly patients may present with angina or precipitate acute coronary syndromes if they have underlying IHD. |
| Intramedullary haemolysis | Megaloblasts are structurally fragile → die within the bone marrow before release. Haemolysis occurs inside bone marrow, so may not see reticulocytes/polychromasia since the problem is within the bone marrow [3]. | Produces a biochemical haemolysis picture (↑LDH, ↑unconjugated bilirubin, ↓haptoglobin) that can be confused with true haemolytic anaemia. The key distinguisher is the low reticulocyte count — in true haemolysis, reticulocytes would be high. |
| High-output cardiac failure | Chronic severe anaemia → compensatory ↑cardiac output → myocardial workload increases → eventually the heart cannot keep up. | Particularly dangerous in elderly patients with pre-existing cardiovascular disease. Warrants cautious transfusion (risk of TACO). |
Why B12 Deficiency Can Be Lethal
"Pernicious" = harmful/injurious — at the time it was described, PA was truly pernicious as it was associated with continuous worsening of symptoms or even death if untreated [3]. Before the discovery of liver extract therapy (1920s) and later injectable B12, pernicious anaemia was universally fatal. Death resulted from severe anaemia, cardiac failure, infection (from leukopenia), or neurological deterioration.
These are the most feared complications because they may be irreversible if treatment is delayed.
| Complication | Mechanism | Clinical Details |
|---|---|---|
| Subacute combined degeneration of the spinal cord (SCD) | ↓SAM → impaired methylation of myelin basic protein; ↑MMA → abnormal fatty acid incorporation into myelin → demyelination of dorsal columns and lateral columns [2] | Affects dorsal (DC-ML) and lateral columns (CST) [2]. Sensory: ↓vibration, ↓proprioception, +Romberg, sensory ataxia. Motor: paraparesis, ↑tone, ↑knee jerks, extensor plantars. Classically: ↑knee jerk (SCD/UMN) + ↓ankle jerk (peripheral neuropathy/LMN) [2]. May progress to paraplegia and incontinence if untreated. Sensory neuropathy takes 6–12 months to correct; others may not improve [2]. |
| Peripheral neuropathy | Demyelination of peripheral nerves from the same mechanisms as SCD | Symmetrical, distal, "glove-and-stocking" paraesthesiae and numbness, starting in the feet. Can occur with or without SCD. |
| Optic neuropathy | Demyelination of optic nerve | Visual loss, reduced colour vision, central scotoma. Rare but well-documented. |
| Cognitive impairment and dementia | Cerebral white matter demyelination + impaired neurotransmitter synthesis (↓SAM → ↓serotonin, dopamine, norepinephrine methylation) | Progressive cognitive decline, poor concentration, memory impairment. B12 deficiency is one of the reversible causes of dementia — but only if caught early. Prolonged deficiency leads to irreversible neuronal loss. |
| Neuropsychiatric manifestations | Same methylation and demyelination mechanisms | Depression, irritability, cognitive slowing, dementia, psychosis [2]. "Megaloblastic madness" — psychosis in the setting of B12 deficiency — is rare but classic. |
B12 deficiency physiology: require ~350 pg/mL for proper neurological function cf 200 pg/mL for haematological function [17]. This explains why neurological damage can occur even when blood counts are still normal — neurons have a higher threshold for B12.
Irreversibility of Neurological Damage
The single most important prognostic factor is duration of neurological symptoms before treatment. Demyelination (loss of myelin sheath around intact axons) is potentially reversible. Axonal degeneration (actual death of the nerve fibre) is NOT reversible. The longer B12 deficiency goes untreated, the more likely axonal loss has occurred → permanent deficit. This is why neurological symptoms should trigger urgent parenteral B12 replacement.
| Complication | Mechanism |
|---|---|
| Hyperhomocysteinaemia | B12 deficiency → ↓methionine synthase activity → homocysteine accumulates. Elevated homocysteine is an independent risk factor for atherosclerosis, coronary artery disease, stroke, and venous thromboembolism. The mechanism involves endothelial dysfunction, oxidative stress, and prothrombotic effects. |
| Cardiovascular disease (atherosclerosis) | Chronic hyperhomocysteinaemia → endothelial injury → accelerated atherosclerosis. Whether B12 replacement reduces cardiovascular events remains debated (trials have been inconclusive), but the biochemical association is well-established. |
| Venous thromboembolism | Hyperhomocysteinaemia is a mild thrombophilic state. Patients with severe B12 deficiency have an increased risk of DVT and PE. |
| Complication | Mechanism |
|---|---|
| Neural tube defects (NTDs) | B12 deficiency in pregnancy → impaired DNA synthesis + ↓SAM (methylation) during critical periods of neural tube closure (weeks 3–4 of embryogenesis). B12 and folate work synergistically in this pathway. |
| Recurrent miscarriage / infertility | Hyperhomocysteinaemia → endothelial dysfunction in placental vasculature → impaired implantation and placentation. |
| Intrauterine growth restriction (IUGR) | Impaired DNA synthesis → reduced fetal cell proliferation. |
| Neonatal B12 deficiency | Exclusively breastfed infants of B12-deficient mothers → failure to thrive, developmental delay, megaloblastic anaemia, neurological deterioration. B12 in breast milk is low if maternal stores are depleted. |
| Complication | Mechanism |
|---|---|
| Atrophic glossitis → predisposition to oral infections | Loss of papillae on tongue → loss of mechanical barrier → increased susceptibility to oral candidiasis and other infections. |
| Angular stomatitis and oral ulceration | Impaired epithelial renewal → chronic mucosal breakdown → secondary infection. |
| Malabsorption (vicious cycle) | Severe B12 deficiency → GI epithelial damage → further impaired nutrient absorption → worsening deficiency. |
Since pernicious anaemia is the most common medical cause of B12 deficiency, its specific complications deserve separate attention:
| Complication | Mechanism | Clinical Relevance |
|---|---|---|
| Chronic atrophic gastritis | Autoimmune attack on gastric parietal cells → mucosal atrophy → loss of acid secretion (achlorhydria) and IF production [3] | Achlorhydria also impairs iron absorption → may develop concurrent iron deficiency anaemia (dimorphic anaemia picture). |
| Gastric carcinoma (adenocarcinoma) | Achlorhydria → ↑microbial colonization of stomach + compensatory ↑gastrin from G-cells (loss of negative feedback) → chronic mucosal stimulation → ↑risk of malignant transformation [2][3] | Upper endoscopy is indicated to screen for atrophic gastritis and carcinoma of stomach [3][15]. Risk is estimated at 2–3× general population. |
| Gastric neuroendocrine tumours (carcinoids) | Achlorhydria → loss of acid-mediated negative feedback on gastrin → sustained hypergastrinaemia → trophic effect on enterochromaffin-like (ECL) cells in gastric body → ECL cell hyperplasia → Type I gastric carcinoid | These are typically small, multifocal, and have a good prognosis compared to sporadic gastric carcinoids. |
| Associated autoimmune diseases | Pernicious anaemia clusters with other organ-specific autoimmune diseases in the context of Polyglandular Autoimmune Syndrome Type 2 (PAS-2) | Autoimmune thyroid disease (Hashimoto's, Graves'), Addison's disease, T1DM, vitiligo, hypoparathyroidism [2]. All patients with PA should be screened for thyroid dysfunction at minimum. |
Gastric Cancer Screening in Pernicious Anaemia
Two gastric diseases associated with pernicious anaemia: (1) Atrophic gastritis and (2) Carcinoma of stomach [3]. Upper endoscopy at diagnosis of PA is recommended. Surveillance endoscopy protocols vary but most centres advocate repeat endoscopy every 3–5 years, particularly in patients with extensive atrophic gastritis or intestinal metaplasia on initial biopsy.
These occur during the correction phase and are important to anticipate:
| Complication | Mechanism | Prevention / Management |
|---|---|---|
| Hypokalaemia | Reticulocyte surge (peaks day 5–10) → rapid cell proliferation → K⁺ shifts intracellularly as it is incorporated into newly forming cells [2] | Monitor serum K⁺ during the first 1–2 weeks of B12 replacement. Supplement potassium if < 3.5 mmol/L. Can be life-threatening (cardiac arrhythmias) if not anticipated. |
| Iron depletion | Rapid erythropoiesis consumes iron stores that were previously "idle" during the period of ineffective erythropoiesis. May develop iron deficiency as evidenced by dimorphic red cells on PBS [2]. | Check ferritin/iron studies; supplement iron orally if stores are low. Dimorphic picture on PBS (simultaneous macrocytes and microcytes) is the hallmark. |
| Worsening neurological deficit from folate monotherapy | Use of folate alone in the presence of B12 deficiency may cause worsening of neurological deficit despite partially masking its haematological deficits [2] | NEVER give folate alone if B12 status is unknown. Always give B12 first or concurrently. |
| Transfusion-associated circulatory overload (TACO) | Chronically anaemic patients have expanded plasma volume (compensatory). Adding transfused volume → pulmonary congestion. | Transfuse slowly (1 unit over 3–4 hours); give furosemide 20–40 mg IV with each unit; transfuse 1 unit at a time and reassess. |
| Injection site haematoma | IM injection in a thrombocytopenic patient (due to pancytopenia from B12 deficiency) | Give subcutaneous in patients with profound pancytopenia [3]. |
| Complication | Mechanism | Notes |
|---|---|---|
| Permanent neurological disability | Prolonged demyelination → secondary axonal degeneration → irreversible loss of neurological function | SCD-related paraparesis, sensory ataxia, incontinence. Some patients are left wheelchair-bound if diagnosis is delayed by months to years. |
| Increased infection risk | Persistent leukopenia from ongoing pancytopenia | Rare if adequately replaced, but possible if compliance is poor with IM injections or oral supplementation. |
| Osteoporosis | Chronic hyperhomocysteinaemia may interfere with collagen cross-linking in bone, reducing bone strength | Epidemiological studies show an association between B12 deficiency and ↑fracture risk, though the causality is debated. |
5. Complications in the Context of Short Gut Syndrome and Post-Gastrectomy
These are surgical contexts where B12 deficiency is an expected sequela and must be actively prevented:
Vitamin B12 deficiency is a late complication of gastrectomy — loss of intrinsic factor secreted by gastric parietal cells [18]. In addition:
- Fat-soluble vitamin (A, D, E, K) deficiency (if Billroth II or Roux-en-Y reconstruction) [18]
- Iron deficiency (↓conversion of Fe³⁺ to Fe²⁺ by gastric acid → ↓iron absorption) [18]
- Dumping syndrome, alkaline reflux gastritis (not directly related to B12 but part of the post-gastrectomy syndrome spectrum)
If the terminal ileum is resected [4][19]:
- Vitamin B deficiency: megaloblastic anaemia, peripheral neuropathy, subacute cord degeneration [4]
- Bile salt malabsorption → steatorrhoea → fat-soluble vitamin deficiency
- B12 deficiency can be accompanied by macrocytic anaemia and neuropsychiatric dysfunction [19]
| System | Complications | Key Mechanism |
|---|---|---|
| Haematological | Severe pancytopenia, intramedullary haemolysis, high-output cardiac failure | Impaired DNA synthesis → ineffective haematopoiesis |
| Neurological | SCD, peripheral neuropathy, optic neuropathy, dementia, psychosis | ↓SAM + ↑MMA → demyelination + axonal loss |
| Cardiovascular | Hyperhomocysteinaemia → atherosclerosis, VTE | ↓Methionine synthase → homocysteine accumulation |
| Reproductive | NTDs, miscarriage, IUGR, neonatal B12 deficiency | Impaired DNA synthesis + ↓methylation in embryogenesis |
| Gastric (PA-specific) | Atrophic gastritis, gastric adenocarcinoma, gastric carcinoid | Achlorhydria + hypergastrinaemia |
| Autoimmune (PA-specific) | Thyroid disease, T1DM, Addison's, vitiligo | Polyglandular autoimmune syndrome Type 2 |
| Treatment-related | Hypokalaemia, iron depletion, folate-masking, TACO, injection haematoma | Rapid cellular proliferation; volume overload; pancytopenia |
| Long-term | Permanent neurological disability, osteoporosis | Irreversible axonal loss; impaired collagen cross-linking |
High Yield Summary — Complications of B12 Deficiency
Disease complications (untreated):
- Haematological: Severe pancytopenia, intramedullary haemolysis (↑LDH, ↑bilirubin, ↓haptoglobin but LOW reticulocytes), high-output cardiac failure
- Neurological (most feared): SCD (dorsal + lateral columns), peripheral neuropathy, dementia, psychosis. May be irreversible if treatment is delayed. Neurons need ~350 pg/mL B12 vs ~200 pg/mL for haematopoiesis.
- Cardiovascular: Hyperhomocysteinaemia → atherosclerosis, VTE
- Reproductive: Neural tube defects, miscarriage, neonatal B12 deficiency
PA-specific complications:
- Atrophic gastritis → gastric adenocarcinoma / gastric carcinoid (screen with upper endoscopy)
- Associated autoimmune diseases (PAS-2): thyroid, Addison's, T1DM, vitiligo
Treatment complications:
- Hypokalaemia (K⁺ shifts intracellularly during reticulocyte surge — monitor and supplement)
- Iron depletion (rapid erythropoiesis consumes iron → dimorphic PBS)
- Folate alone = neurological worsening (masks anaemia but accelerates SCD)
- IM haematoma in pancytopenic patients → use SC route instead
Active Recall - Complications of B12 Deficiency
References
[2] Senior notes: Ryan Ho Haemtology.pdf — Pages 29–30, Clinical features, diagnostic evaluation, and management of B12 deficiency [3] Senior notes: Block A - Pallor_ diagnosis of anaemia; nutritional anaemia; anaemia of systemic diseases.pdf — Pages 16, 18–20, B12 absorption, pernicious anaemia presentation, investigations, and replacement [4] Senior notes: Ryan Ho GI.pdf — Pages 126–127, Short gut syndrome clinical features and complications [15] Lecture slides: GC 076. Pallor_diagnosis of anaemia; nutritional anaemia; anaemia of systemic diseases.pdf — Pages 5, 27 [17] Senior notes: Ryan Ho Psychiatry.pdf — Page 109, B12 deficiency in chronic alcoholism and neurological threshold [18] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf — Page 420, Complications of gastrectomy [19] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf — Page 1073, Complications of short bowel syndrome
High Yield Summary
Definition: Vitamin B12 (cobalamin) deficiency — inadequate B12 stores → impaired DNA synthesis (megaloblastic anaemia) + demyelination (neurological disease).
Key Biochemistry:
- Methyl-B12 → methionine synthase (homocysteine → methionine; regenerates THF for DNA synthesis; ↓ → ↑homocysteine)
- Adenosyl-B12 → methylmalonyl-CoA mutase (MMA → succinyl-CoA; ↓ → ↑MMA → abnormal myelin)
- MMA distinguishes B12 def from folate def (MMA ↑ only in B12 def)
Causes (SAQ!): Diet (vegan) | Pernicious anaemia (anti-IF, anti-parietal cell Ab) | H. pylori | Post-gastrectomy | Terminal ileal disease/resection | Blind loop syndrome | Fish tapeworm | Drugs (PPI, metformin) | N₂O
PBS: Oval macrocytes + hypersegmented neutrophils (≥ 6 lobes)
Classic Triad: Megaloblastic anaemia + Glossitis + Neuropsychiatric features (SCD)
SCD Pattern: Dorsal columns (↓proprioception/vibration, +Romberg) + Lateral columns (UMN signs) + Peripheral neuropathy. Classic: ↑knee jerk + ↓ankle jerk.
Pernicious Anaemia: Anti-IF Ab (specific, insensitive ~50–70%) + Anti-parietal cell Ab (sensitive, non-specific ~85–90%). Associated with atrophic gastritis, ↑risk gastric CA, PAS-2.
Hong Kong Pearl: Megaloblastic anaemia in HK = B12 deficiency (folate deficiency anaemia essentially does not occur in HK).
Neurological damage can occur WITHOUT anaemia — neurons need higher B12 levels than BM.
High Yield Summary — Differential Diagnosis
Three clinical entry points for DDx:
- Macrocytic anaemia → megaloblastic (B12 def, folate def, drugs, MDS) vs non-megaloblastic (alcohol, liver, hypothyroid, haemolysis, myeloma)
- Myelopathy / neuropathy → SCD (B12 def), MS, NMO, cord compression, copper deficiency, diabetic neuropathy
- Glossitis / mucocutaneous → B12 def, folate def, iron def, riboflavin def, pellagra
Key distinguishers:
- PBS: oval macrocytes + hypersegmented neutrophils = megaloblastic
- MMA: ↑ in B12 def only (NOT folate def) — the single most specific distinguishing test
- SCD (dorsal + lateral column signs): B12 def only (NOT folate def)
- MCV > 120 fL: essentially only pernicious anaemia or chemotherapy
- HK pearl: folate deficiency anaemia essentially does not exist in HK
Don't miss: MDS can mimic B12 deficiency (pancytopenia + macrocytosis); distinguished by dysplastic (not hypersegmented) neutrophils and failure to respond to B12 replacement → BM biopsy needed.
High Yield Summary — Diagnosis of B12 Deficiency
Three-pillar diagnosis:
- Clinical suspicion (anaemia, glossitis, SCD, neuropsychiatric)
- Haematological evidence (macrocytosis + oval macrocytes + hypersegmented neutrophils + pancytopenia)
- Biochemical confirmation (↓holotranscobalamin; ↑MMA for borderline cases)
GC 076 Lecture slide investigations for suspected PA:
- Serum Vitamin B12 level
- Serum holotranscobalamin (preferred modern test)
- Serum and red cell folate level
- Anti-parietal cell Ab — sensitive, less specific
- Anti-IF Ab — specific, less sensitive
- Upper endoscopy — atrophic gastritis + CA stomach screening
- Schilling test — historical, obsolete in HK
- BM Examination — not routinely needed, except when incompatible with PA
Key metabolite interpretation:
- ↑MMA + ↑Hcy = B12 deficiency
- Normal MMA + ↑Hcy = Folate deficiency
- Both normal = Neither deficiency
Don't forget: Intramedullary haemolysis gives ↑LDH, ↑bilirubin, ↓haptoglobin — mimics haemolysis, but reticulocytes are LOW (not high).
MCV > 120 fL = pernicious anaemia or chemotherapy — nothing else reliably gets this high.
High Yield Summary — Management of B12 Deficiency
Route decision:
- Medical/surgical cause (PA, gastrectomy, ileal disease) → parenteral (IM standard, SC if pancytopenic)
- Dietary cause → oral (1000 μg/day)
- New evidence: high-dose oral (1000 μg) can work even in malabsorption via passive diffusion, but IM remains standard
Critical safety rule: NEVER give folate alone if B12 status is unknown — it will mask the anaemia while worsening neurological damage. If urgent, give BOTH B12 + folate.
Monitoring response:
- Reticulocyte peak: days 5–10
- Hb rises ~1 g/dL per week
- Watch for hypokalaemia and iron depletion during reticulocyte surge
- Neurological recovery: 6–12 months for sensory; motor/SCD may be irreversible if delayed
Lifelong replacement: PA, post-gastrectomy, ileal resection, strict vegans
Pernicious anaemia additionally requires: Upper endoscopy (atrophic gastritis + gastric CA screening); screening for autoimmune comorbidities (thyroid, T1DM, Addison's)
High Yield Summary — Complications of B12 Deficiency
Disease complications (untreated):
- Haematological: Severe pancytopenia, intramedullary haemolysis (↑LDH, ↑bilirubin, ↓haptoglobin but LOW reticulocytes), high-output cardiac failure
- Neurological (most feared): SCD (dorsal + lateral columns), peripheral neuropathy, dementia, psychosis. May be irreversible if treatment is delayed. Neurons need ~350 pg/mL B12 vs ~200 pg/mL for haematopoiesis.
- Cardiovascular: Hyperhomocysteinaemia → atherosclerosis, VTE
- Reproductive: Neural tube defects, miscarriage, neonatal B12 deficiency
PA-specific complications:
- Atrophic gastritis → gastric adenocarcinoma / gastric carcinoid (screen with upper endoscopy)
- Associated autoimmune diseases (PAS-2): thyroid, Addison's, T1DM, vitiligo
Treatment complications:
- Hypokalaemia (K⁺ shifts intracellularly during reticulocyte surge — monitor and supplement)
- Iron depletion (rapid erythropoiesis consumes iron → dimorphic PBS)
- Folate alone = neurological worsening (masks anaemia but accelerates SCD)
- IM haematoma in pancytopenic patients → use SC route instead
Megaloblastic Anaemia Overview
Megaloblastic anaemia is a type of macrocytic anaemia caused by impaired DNA synthesis, most commonly due to vitamin B12 or folate deficiency, resulting in large, abnormal erythroid precursors (megaloblasts) in the bone marrow.
Folate Deficiency
Folate deficiency is an inadequate level of folate (vitamin B9) in the body, leading to impaired DNA synthesis and megaloblastic anemia.